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SUMMARY
The removal of noncoding sequences, or introns, from eukaryotic messenger RNAs is
an essential step in the expression of genetic information. Two types of introns are
removed by dedicated spliceosomes. The majority of introns are spliced by the U2-
dependent  spliceosome,  whereas  a  small  fraction  of  introns,  less  than  0.5%,  are
removed by a dedicated U12-dependent spliceosome. Although the two splicing
pathways are highly similar, differences exist in the initial step of intron recognition.
The rationality of maintaining parallel spliceosomes has remained unclear and is
thought to stem from the suggested regulatory functions of the minor type introns.
The U12-dependent spliceosome removes introns at a slower rate than the major
spliceosome, and therefore the minor introns may constitute a rate-limiting step in the
processing of the mRNA.
In this work, I have investigated the regulation of the minor spliceosome via a negative
feedback loop that relies on alternative splicing and nonsense mediated decay. Pre-
mRNAs encoding U11-48K and U11/U12-65K proteins of the minor intron recognition
particle, U11/U12 small nuclear RNP, are alternatively spliced. Alternative splice site
usage is activated upon binding of the U11/U12 di-snRNP on regulatory motifs
resembling bona fide spliceosomal 5ʹ splice sites. The alternative isoforms contain
premature termination codons leading to destabilization of the transcript in question,
or display differential cellular localization. I have further characterized the splicing
regulatory element and the role of U11-35K protein required for its activation. The
findings point to the existence of a considerable selection pressure maintaining the
important motifs of the regulatory element, as both the motifs and their location
relative to each other are highly conserved in distant organisms and can be found both
in animals and plants, highlighting the importance of regulating the intron recognition
step of the U12-dependent splicing pathway.
The rate-limiting characteristics of U12-type introns are well known but earlier works
have investigated only a small number of introns. In the final part of this work, RNA
sequencing was performed and the results confirm that U12-type introns are less
efficiently removed on a transcriptome-wide scale. I also investigated a hypothesis
suggesting that slowly processed mRNAs are targeted by nuclear decay. Following the
inactivation of RNA exosome components, transcripts with unspliced U12-type introns
are stabilized while U2-type introns in the same transcripts remain unaffected. This
supports the results from previous work on the delayed processing of U12-type introns
and indicates a mechanism for their role in the regulation of eukaryotic gene
expression.
viii
TIIVISTELMÄ
Aitotumallisten eliöiden, kuten eläinten ja kasvien, geeneille on tyypillistä koodaavien
jaksojen jakautuminen useampaan osaan, joita kutsutaan eksoneiksi. Eksonien välisiä,
koodaamattomia jaksoja puolestaan kutsutaan introneiksi, joiden poisto eli silmukointi
on välttämätöntä oikean proteiinin tuottamiseksi. Useilla aitotumallisilla esiintyy
kahdenlaisia introneita, joista huomattavasti yleisempiä ovat U2-tyypin intronit. U12-
tyypin introneita on vain noin 0,5 % ihmisen kaikista introneista, ja silti niiden poistoa
varten on erikoistunut, ns. U12-tyypin spliseosomi. Mekanismiltaan ja kompositioltaan
spliseosomit ovat huomattavan samalaisia keskenään, lukuun ottamatta snRNA-
molekyylejä sekä joitakin proteiineja U11/U12 di-snRNP-kompleksissa, joka sitoutuu
U12-tyypin intronien tunnistussekvensseihin. Kahden päällekkäisen
silmukointikompleksin olemassaoloa on selitetty mm. U12-tyypin silmukoinnin
hitaudella, jonka johdosta U12-tyypin introneita sisältävien geenien ilmentymistä voisi
säädellä erikseen.
Väitöskirjassani olen tutkinut U11/U12 di-snRNP:n itsesäätelyä, joka toimii di-snRNP:n
proteiineja 48K:ta ja 65K:ta koodaavien geenien introneissa olevien, vaihtoehtoista
silmukointia säätelevien tunnistussekvenssien avulla. Vaihtoehtoinen silmukointi
aktivoituu, kun 48K-proteiinia on runsaasti, ja aiheuttaa lähetti-RNA-molekyylien
tuhoutumisen ns. nonsense mediated decay –mekanismilla (48K) tai lähetti-RNA:n
jäämiseen tumaan (65K), missä se ei voi ohjata proteiinisynteesiä. Olen myös tutkinut
kyseistä vaihtoehtoista silmukointia kontrolloivan sekvenssin (lyh. USSE, U11 snRNP-
binding splicing enhancer) esiintymistä ja variaatiota eri lajeissa sekä proteiineja, jotka
vaikuttavat aktivaatioon. Erityisesti 35K-proteiinilla ja sen SR-domeenilla huomattiin
olevan tärkeä rooli aktivaation välittäjänä. Havaittiin, että USSE-sekvenssissä on tiettyjä
kriittisiä etäisyysparametreja, joiden säilyttäminen on tärkeää säätelyn kannalta.
Lisäksi tulokset viittaavat siihen, että USSE:n molemmat osiot ovat välttämättömiä ja
todennäköisesti kaksi snRNP:ta sitoutuu niihin samanaikaisesti.
U12-tyypin silmukoinnin hitauden vaikutusta geenien ilmentymiseen tutkittiin
osatyössä, jossa tiettyjen tuman RNA-hajotusentsyymien (eksosomin) inaktivoinnin
jälkeen sekvensoitiin tuman RNA-molekyylejä ja analysoitiin intronien retentiota sekä
poiston kinetiikkaa. Työssä havaittiin, että U12-tyypin introneita poistetaan hitaammin
ja osa niitä sisältävistä lähetti-RNA:ista hajotetaan jo tumassa. U12-tyypin intronien
poiston kinetiikan todettiin tutkituissa tapauksissa olevan huomattavasti hitaampaa ja
reagoivan voimakkaammin eksosomin inaktivaatioon kuin yleisten intronien. Tulokset
sopivat yhteen aiemmin julkaistujen yksittäistapausten kanssa ja osaltaan selittävät
rinnakkaisen spliseosomin tarvetta.
1 Review of the literature
1 REVIEW OF THE LITERATURE
1.1 INTRONS AND EXONS
1.1.1 Evolutionary costs and benefits of introns
The majority of genes in eukaryotic genomes are encoded in a discontinuous manner,
that is, coding sequences are found as fragments dispersed within long stretches of
noncoding sequence. Expression of the correct gene products requires accurate joining
of the protein-coding sequences known as exons, and the removal of noncoding intron
sequences. Considered “junk DNA” for decades, it has now become apparent that
introns play many roles in eukaryotic gene expression (reviewed in Le Hir et al., 2003).
Removal of intronic sequences, a process called RNA splicing, is one of the central
steps in eukaryotic gene expression pathway. Intron removal is highly regulated,
mainly through a layer of information which is located both in the intronic and exonic
sequences and often overlaps with protein-coding information needed for translation.
The presence of introns can be beneficial for cells or organisms in many ways. In a
process called alternative splicing (see section 1.4.3) a single gene can code for
multiple gene products, thus increasing protein diversity and therefore the coding
capacity of eukaryotic genomes. Exon shuffling and duplication/deletion events
accelerate evolution by producing raw material for evolutionary selection processes.
Intron sequences can provide sites for and increase the likelihood of recombination
processes, but they can also buffer imprecisions in recombination, thus facilitating the
evolutionary emergence of new exons or even entire genes (reviewed by Patthy, 1999).
Introns also have more immediate effects on many steps of gene expression. Their
presence enables transcriptional regulation because, as regions free of selection
pressures imposed by protein coding information, introns are a common location for
transcriptional enhancer (or suppressor) elements (Rossi and de Crombrugghe, 1987;
Stergachis et  al.,  2013).  More  directly,  introns  stimulate  RNA  polymerase  II  (Pol  II)
initiation and elongation rate (Brinster et al., 1988; Fong and Zhou, 2001; Furger et al.,
2002; Kwek et al., 2002). Also, pre-mRNA splicing is linked to subsequent steps of gene
expression as a consequence of exon junction complexes (EJC) deposited on the mRNA
during splicing, which stimulates many subsequent processes such as nuclear export,
mRNA translation, and mRNA quality control (Le Hir et al., 2001; Nott et al., 2004).
Introns contain many RNA genes that do not code for proteins (noncoding RNA or
ncRNA), and therefore not all excised introns are completely discarded after splicing
(Rearick et al., 2011). The classification to coding and non-coding sequences is, in fact,
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an  oversimplification  as  it  has  become  evident  that  for  a  growing  number  of  ncRNA
genes RNA is the final gene product. Furthermore, in many instances introns are
processed separately to give rise to stable RNA products such as microRNAs and small
nucleolar RNAs (miRNAs and snoRNAs; Kiss and Filipowicz, 1995; Rodriguez et al.,
2004). There are also extreme cases where introns code for stable RNA products while
the exonic sequences do not have any apparent function (Tycowski et al., 1996). It has
also been argued that the complexity of eukaryotic gene expression is an intricate
strategy to ensure the genuineness of expression, that is, to defend against genomic
parasites, such as transposable elements and viruses which do not necessarily
participate in such complex processes (Madhani, 2013).
On the other hand, the transcription of such additional lengths of RNA comes with a
cost. This is evident from the genomic organization of housekeeping genes and highly
expressed genes which have shorter and fewer introns (Castillo-Davis et  al., 2002;
Eisenberg and Levanon, 2003). This may be because the presence of introns causes a
delay in the synthesis of a transcript, both as an increased transcription time and the
time spent in the processing steps. Such delays can sometimes be beneficial, for
example in controlling the timing of mRNA expression and even in establishing
oscillating expression patterns (Takashima et al., 2011). Another drawback involving
introns and splicing is that owing to its complexity, the system is sensitive to mutations
within the splicing factors or within the necessary sequence elements on pre-mRNAs,
which can cause serious misregulation of gene expression and lead to various diseases,
particularly in neurological diseases and cancer (Ward and Cooper, 2010; Abdel-Wahab
and Levine, 2011). And finally, while the eukaryotic gene expression may have
developed to a high degree of complexity in order to avoid the expression of parasitic
sequences, certain viruses exploit this complexity to their own advantage to produce
highly regulated gene expression programs (for example HIV; Stoltzfus and Madsen,
2006).
1.1.2 Prevalence and origins of introns
Intron density and size varies considerably between different eukaryotic genomes.
Unicellular eukaryotes such as the bakerʹs yeast Saccharomyces cerevisiae tend to have
few  introns.  Only  4  %  of S. cerevisiae genes  have  introns,  mostly  only  one  per  gene
with a short average length (256 bp, range 50-1000 bp; Kupfer et al., 2004). In humans,
on the other hand, mean intron length is 3300 bp and on average there are 7.8 introns
per gene (Lander et al., 2001). Clearly, in more complex eukaryotes the opportunities
provided by enhanced regulatory capacity outweigh the costs of maintaining longer
introns, or at least the longer introns do not pose a significant reduction of fitness
during the long generation time of these organisms (Rogozin et al., 2012).
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The origin of spliceosomal introns has been debated extensively, with the discussion
centering around two hypotheses called “introns-early” and “introns-late” (Roy and
Gilbert, 2006). The introns-early theory postulates that introns were already present in
the early genomes, and that the present-day genes were originally evolved from short
coding fragments surrounded by noncoding sequences. According to this theory,
present-day streamlined genomes (found in Bacteria, Archaea and some unicellular
eukaryotes) that show only a few or no introns, have emerged through a process of
intron loss during evolution (Darnell, 1978; Doolittle, 1978). In contrast, the introns-
late theory postulates that prokaryotic genomes represent ancestral genome
organization, and that present-day intron-containing eukaryotic genomes emerged
through insertion or invasion of introns to the ancestral genomes (Logsdon, 1998). A
variant of introns-early theory, called “introns-first”, proposes that the origin of introns
lies  in  the  RNA  world  (Gilbert  and  de  Souza,  1999).  It  postulates  that  introns  have
evolved from ribozymes, and protein-coding genes from exonic fragments that
accumulated to the RNA genome over time (Jeffares et al., 1998).
Comparison of a large number of eukaryotic genomes has revealed that intron-poor
genomes have undergone extensive intron loss, which supports the introns-early
theory (Csuros et  al.,  2011).  Only  one  sequenced  eukaryotic  genome,  that  of
Hemiselmis andersenii, has been found to be completely intronless (Lane et al., 2007).
However, H. andersenii is an endosymbiont with a heavily reduced genome, and even
as such rather exceptional, as other reduced genomes of parasitic and deep-branching
eukaryotes do contain introns (Nixon et al., 2002; Simpson et al., 2002; Vanácová et al.,
2005). Intron gain has occurred in some lineages, especially the Metazoans, but only
on a limited number of occasions (Csuros et al., 2011). Thus, it seems evident now that
the genome of the last eukaryotic common ancestor was intron-rich, and genome
streamlining has led to intron loss in many lineages.
1.1.3 Self-splicing introns
Introns in eukaryotic genes are thought to have evolved from self-splicing RNA
elements. The latter are capable of autocatalytic excision from host RNA practically
without the help of proteins, thanks to a complex secondary structure. They may also
contain an intron-encoded reverse transcriptase and homing endonuclease that
enables retrotransposition into new genomic sites. Intron-encoded RNA maturase is
also required for splicing in vivo but not in vitro. Self-splicing introns can be found in
bacteria and organelles of various eukaryotes, such as fungi and plants, and are
classified according to their catalytic mechanism as group I and group II introns. (Bonen
and  Vogel,  2001;  Fedorova  and  Zingler,  2007).  Both  self-splicing  intron  types  employ
two sequential transesterification reactions initiated by a nucleotide, but differ in the
source of the nucleotide (external or internal) and the secondary structure the intron
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folds into. Group I self-splicing introns utilize an external GTP molecule to initiate the
first nucleophilic reaction. Group II self-splicing introns resemble spliceosomal introns
in their splicing mechanism, initiated by a bulged adenosine residue within the intron
itself, and resulting in spliced exons and an excised lariat intron (see section 1.3.1).
Group II self-splicing introns are thought to be the evolutionary ancestors of
spliceosomal small nuclear RNAs (snRNAs) and introns due to similarities in secondary
structure and the catalytic mechanisms of intron removal. Their mobility due to
retrotransposition also presents an attractive hypothesis on the mechanism of intron
gain  in  very  early  organisms.  However,  no  conclusive  evidence  exists  to  resolve  the
origin of spliceosomal snRNAs and introns, i.e. whether they evolved from group II
introns or whether the two groups share a common ancestor (Penny et  al., 2009).
Alternatively, they may also have risen not through common ancestry but via
convergent chemical evolution (Weiner, 1993).
1.1.4 Splice sites
Spliceosomal introns and group II introns contain three short conserved sequence
elements. Intron ends are known as the 5ʹ splice site (5ʹss) and 3ʹ splice site (3ʹss)
sequences, while the branch point sequence (BPS) lies slightly upstream of the 3ʹss
(Figure 1). Most introns are processed by the canonical U2-dependent spliceosome,
which recognizes a 5ʹ splice site of the consensus sequence AG/GTAAG (where /
denotes exon-intron boundary). The consensus sequence for the 3ʹss is shorter,
consisting of only three nucleotides, YAG, at the end of the intron, preceded by the
polypyrimidine tract (PPT). In close proximity to the 3ʹss, typically 20-40 nt upstream, is
the branch point sequence (Gao et al., 2008; Corvelo et al., 2010), containing the
branch point adenosine, which is used in the first step of catalysis. BP sequences are
highly degenerate in multicellular organisms, only in yeasts and other fungi do they
follow a strict consensus sequence (Tolstrup et al., 1997; Kupfer et al., 2004; Gao et al.,
2008). BP can be accurately predicted, however, using an algorithm that predicts U2
snRNA binding affinity combined with PPT strength and 3ʹ terminal dinucleotide
(Corvelo et al., 2010). U2-type intron splice sites are overall highly degenerate, only the
terminal dinucleotides GT-AG of the intron are 99 % invariant (Sheth et  al., 2006).
Typically, in intron-poor genomes the adherence to consensus splice sites is more
stringent, whereas in genomes with high intron density, more deviation is tolerated
(Irimia et al., 2007).
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Figure 1. Conserved sequences of U2- and U12-type introns. Adapted with modifications from
Turunen et al. (2013a)
A parallel type of introns exists in diverse eukaryotic lineages. It was originally
discovered due to unusual splice sites that diverged significantly from the canonical
GT-AG rule found in the majority of introns. Therefore, this group of introns was
originally known as AT-AC introns (Jackson, 1991). Shortly afterwards the group was
renamed as U12-type introns according to an snRNA component of the novel
spliceosome (called U12-dependent or minor spliceosome) involved in the removal of
these introns (see section 1.2.2.; Sharp and Burge, 1997). Renaming was further
prompted by the discoveries that the normal, or U2-type, introns can also have AT-AC
termini and that an AT-AC intron with terminal nucleotides mutated to GT-AG was still
spliced by the minor spliceosome (Dietrich et al., 1997; Wu and Krainer, 1997). The 5ʹ
splice site consensus for U12-type introns is /RTATCCTTT (Burge et al., 1998; see Figure
1). The polypyrimidine tract is missing in these introns; instead, the branch point
sequence is highly conserved among U12-type introns (TTCCTTAAC; see Figure 1).
Dinucleotides  at  the  3ʹss  splice  site  are  typically  AG/  for  introns  with  GT  5ʹss  and AC/
for introns with AT 5ʹss, although a few introns with atypical terminal dinucleotides
have been experimentally shown to be spliced by the U12-dependent spliceosome
(Dietrich et al., 1997; Levine and Durbin, 2001; Hastings et al., 2005; Lin et al., 2010).
1.1.5 Intron types in different organisms
While U2-dependent introns are ubiquitous in virtually all eukaryotic genomes (see
above), the U12-dependent introns show more restricted distribution. They can be
found in the majority of plant and animal species and some fungi as well as a few deep-
branching  single-celled  eukaryotes.  However,  they  are  missing  from  a  number  of
species, including the common model organisms S. cerevisiae and Caenorhabditis
elegans (Burge et al., 1998; Levine and Durbin, 2001; Russell et al., 2006; Sheth et al.,
2006; Bartschat and Samuelsson, 2010). Their absence in many organisms whose
relatives still retain them suggests that the U12-dependent spliceosome has been lost
on several occasions during evolution following extensive intron loss and conversion of
U12-type introns to U2-type (Turunen et al., 2013a).
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Conversion of U12-type introns to U2-type introns has been suggested to be more
common than in the opposite direction (Burge et al., 1998). This is because the
consensus sequence for U2-type splice sites is more relaxed, causing a higher
likelihood of a small number of mutations leading to the loss of recognition by the U12-
dependent spliceosome and switch to the U2-dependent spliceosome. Also, the
cooperativity in 5ʹss and BPS recognition (see section 1.3.3; Frilander and Steitz, 1999)
requires that both of these sequences should be compatible with the U12-dependent
spliceosome. Thus a single point mutation in either site can lead to conversion of the
intron type. Inspection of orthologous U12-type introns in several genomes has indeed
confirmed that U12-type to U2-type conversion is a frequent process; however, loss of
U12-type introns (instead of replacement with U2-type introns) is noted to be even
more common (Lin et al., 2010). Loss of introns is more common than intron gain for
introns in general (Coulombe-Huntington and Majewski, 2007); however, the overall
loss of U12-type introns is greater than of U2-type introns given that the former is a
sum of both genuine loss and intron conversion events.
If U12-dependent introns are more easily converted to U2-dependent introns, they
must have been more common earlier in evolution. As discussed above (section 1.1.2),
general purging of introns has occurred in organisms that have short generation times
and large populations. In this light it is not surprising that genomic streamlining has led
to the complete loss of the parallel minor spliceosome in some lineages (Dávila López
et al., 2008; Bartschat and Samuelsson, 2010). Possible advantages of maintaining two
splicing systems are discussed in section 1.5.3.
The origin of the U12-dependent spliceosome is as perplexing as its perseverance. The
two  systems  are  similar  and  share  components  (see  section  1.2.2)  but  are  clearly
specialized. Their degree of similarity suggests a common ancestor, yet this may be the
result of convergent evolution guided by a shared pool of protein factors (Burge et al.,
1999). The ancestral group II self-splicing intron that possibly invaded the genome of a
eukaryotic ancestor may have duplicated early, and the two splicing systems may have
diverged from there. A fission/fusion model suggests that the genetic drift was
facilitated by a split into separate lineages, which then fused to became the ancestor of
modern eukaryotes (Burge et  al.,  1998).  However,  it  has  been  argued  that  such
genomic drift would have made the diverged genomes incompatible to fusion, and
therefore another scenario explaining the present day situation is the seeding of a
genome with two similar but nonidentical group II self-splicing introns (Lynch and
Richardson, 2002).
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1.2 SPLICEOSOME COMPONENTS
1.2.1 Components of the U2-dependent spliceosome
The two parallel types of introns are excised in the nucleus by two parallel
spliceosomes. The U2-dependent spliceosome consists of five small nuclear RNAs, U1,
U2, U4, U5 and U6, and together with protein components, they form the small
nuclear ribonucleoprotein particles (snRNPs). The snRNAs fold into conserved
secondary  structures  (Figure  2).  U1,  U2,  U4,  and  U5  snRNAs  contain  a  2,2,7-
trimethylguanosine (m3G) cap at their 5ʹ end, and a uridine-rich binding site for Sm
proteins (listed in Table 1), which are assembled into a ring structure around the
snRNAs during their maturation (Patel and Bellini, 2008; Pomeranz Krummel et  al.,
2009; Leung et  al.,  2011).  U6  has  a  similar  structure  composed  of  Sm-like  (Lsm2-8)
proteins binding to the U-rich 3ʹ end and is capped by a γ-monomethyl cap structure
(Singh and Reddy, 1989; Zhou et al., 2014). The Sm-class snRNAs are transported to the
cytoplasm after transcription to be loaded with the Sm ring and hypermethylated at
the cap, which triggers nuclear import (Fischer et al., 1993). The final steps of the Sm-
class  snRNPs  takes  place  in  the  Cajal  bodies  (see  section  1.5.1;  Sleeman and Lamond,
1999). In contrast, the biogenesis of U6 is entirely nuclear (Will and Lührmann, 2001).
In addition to common proteins, each snRNP contains unique proteins (reviewed by
Will and Lührmann, 2011). U1-specific proteins U1A and U1-70K bind directly to U1
snRNA, while U1C associates via protein-protein interactions (Scherly et al., 1989;
Surowy et al., 1989; Nelissen et al., 1991; Pomeranz Krummel et al., 2009). U2 snRNP
contains the specific proteins U2Aʹ and U2Bʺ (Scherly et al., 1990; Price et al., 1998) in
addition to the multiprotein complexes named SF3a and SF3b (Brosi et al., 1993;
Krämer et al., 1999). U4 and U6 snRNAs associate with each other via extensive base
pairing, and together with specific proteins (listed in Table 1) form the U4/U6 di-snRNP
(Teigelkamp et  al., 1998; Nottrott et al., 1999; Makarova et  al., 2002; Nottrott et  al.,
2002). U5 is the largest of the spliceosomal snRNPs, and contains nine specific proteins
listed in Table 1 (Behrens and Lührmann, 1991; Mougin et al., 2002). Many U5-specific
proteins perform critical functions in dynamic rearrangements of the spliceosome and
splicing catalysis. The most notable are the large multifunctional Prp8/U5-220K which
makes contacts with the 5ʹ exon, BPS and 3ʹss, providing a scaffold for the catalytic
core; RNA helicases Brr2/U5-200K and Prp28/U5-100K; and the GTPase Snu114/U5-
116K (Grainger and Beggs, 2005; Small et al., 2006; Bessonov et al., 2008; Häcker et al.,
2008; Valadkhan and Jaladat, 2010). U5 associates with U4/U6 di-snRNP to form a
ternary complex termed the U4/U6.U5 tri-snRNP (Black and Pinto, 1989). There is no
evidence of RNA-RNA base-pairing interactions bridging U4/U6 to U5; instead, the tri-
snRNP is held together by protein-protein interactions (Liu et al., 2007). The assembled
U4/U6.U5 tri-snRNP contains several proteins not present in the individual snRNP
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complexes, which are proposed to account for the bridging interactions (Bordonné et
al., 1990; Makarov et al., 2002; Mougin et al., 2002; Will and Lührmann, 2011).
A large number of non-snRNP proteins associate with the spliceosome, and in fact, the
total count of spliceosomal proteins has been placed as high as 150-300 proteins, as
identified in purification and mass spectrometry analyses of different spliceosomal
complexes (reviewed by Valadkhan and Jaladat, 2010). Comparison of spliceosomes
from different eukaryotes revealed that a core set of proteins is conserved between
yeast, Drosophila melanogaster and human spliceosomes, but metazoan complexes
contain considerably more proteins (Fabrizio et al., 2009). The dynamic changes that
the spliceosome undergoes during the splicing steps (see 1.3.2) are reflected in the
protein composition as well; proteins enter and leave at specific steps (Fabrizio et al.,
2009), when their enzymatic activities as peptidyl-prolyl cis/trans-isomerases, helicases,
kinases and other protein and RNA-modifying enzymes are employed. Consequently,
there are some discrepancies in reported numbers of bona fide spliceosomal
components. These arise from the dynamic nature of the spliceosome combined with
differences in the experimental settings and cutoff criteria.
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Figure 2. Secondary structures of human spliceosomal snRNAs.
The sequences interacting with 5ʹss or BPS are marked with a black line, the binding sites for Sm
proteins are boxed, and the sequences involved with U2/U6 or U12/U6atac interactions are
highlighted in grey. Nucleotide modifications are omitted. Adapted with modifications from
Turunen (2012). Structures are as published by Yu et al. (1999) for U1, U2, and U5, Nottrott et al.
(2002) for U4, U6, U4atac, and U6atac, Tarn and Steitz (1997) for U11, and Sikand and Shukla
(2011) for U12.
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1.2.2 Components of the U12-dependent spliceosome
Analogous to the major spliceosome, the U12-dependent spliceosome is composed of
five snRNPs. U11, U12, U4atac and U6atac replace the U1, U2, U4 and U6, respectively,
whereas  U5  is  shared  between  both  spliceosomes  (Hall  and  Padgett,  1996;  Tarn  and
Steitz,  1996a,  b).  At  sequence  level  the  U12-type  snRNAs  are  not  similar  to  U2-type
snRNAs; U11 and U12 share no sequence similarity with their counterparts U1 and U2
(Montzka and Steitz, 1988), and U4atac and U6atac show only partial homology to U4
and U6, with 40 % similarity (Tarn and Steitz, 1996a). However, all four snRNAs fold to
highly similar secondary structures when compared with major snRNAs, and U4atac
base  pairs  with  U6atac  in  a  manner  similar  to  U4  and  U6  (see  Figure  2;  Padgett  and
Shukla, 2002). U5 associates with U4atac and U6atac to form the minor tri-snRNP
U4atac/U6atac.U5 (Tarn and Steitz, 1996a). In contrast to the U2-type snRNPs, U11
and U12 form a stable di-snRNP where the individual snRNPs are connected via
protein-protein interactions, but the cell also contains a pool of a free U11 snRNP
(Wassarman and Steitz, 1992b; Benecke et al., 2005; Turunen et al., 2008).
U12-type snRNAs associate with many of the same proteins as major snRNAs. U11, U12
and U4atac are complexed with the Sm heptameric protein ring, and U6atac with the
Lsm counterpart (Montzka and Steitz, 1988; Tarn and Steitz, 1996a; Will et  al., 1999;
Schneider et al., 2002). Indeed, most (if not all) of the minor U4atac/U6atac.U5 tri-
snRNP proteins are shared with the major tri-snRNP, and U4 snRNA can even
substitute for U4atac if it is mutated so that it base-pairs with U6atac (Luo et al., 1999;
Schneider et  al., 2002; Shukla and Padgett, 2004). In contrast, the U11/U12 di-snRNP
contains a number of proteins unique to the U12-dependent spliceosome. SF3a protein
complex  is  not  present  in  the  U11/U12  di-snRNP,  while  SF3b  complex  is  (Will et al.,
2004). Other missing proteins are the U1-specific proteins U1A, U1-70K and U1C.
Instead, the U11/U12 di-snRNP contains seven proteins designated 65K, 59K, 48K, 35K,
31K, 25K, and 20K (Will et al., 2004). Of these, 48K has a critical role in the sequence
specific recognition of the 5ʹss, and also contributes to the stability of the di-snRNP via
interactions with the 59K protein (Turunen et al.,  2008).  Due  to  a  similar  domain
structure, 35K has been suggested to act as a functional analog of U1-70K, and likewise,
structures of the 20K and 65K proteins are reminiscent of the U1C and U1A/U2Bʺ
proteins, respectively (Will et al., 2004). 65K binds U12 snRNA and interacts with the
59K protein of U11 snRNP, bringing the di-snRNP together (Benecke et al., 2005).
Consistently, mutations of the human 65K gene cause the dissociation of the di-snRNP,
aberrant U12-dependent splicing, and developmental defects in patients (Argente et
al., 2014).
U12-type snRNPs are less abundant than their major snRNP counterparts, numbering
in  mammalian  cells  approximately  2  x  103 to  104 particles per cell, or ~100-fold less
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than major snRNPs (Montzka and Steitz, 1988; Tarn and Steitz, 1996a). This is not
surprising as the introns excised by the U12-dependent spliceosome are also much less
common; however, the reports about the effect of minor snRNP abundance on U12-
dependent splicing rate are conflicting (Pessa et al., 2006; Younis et al., 2013, see also
section 1.5.3). Even so, defects in the snRNPs are not tolerated in cells, as mutations of
the human minor snRNP components cause severe developmental defects that result
from disruption of RNA-protein interactions (Edery et  al., 2011; He et  al., 2011;
Argente et al., 2014; Jafarifar et al.,  2014).  Defective  minor  snRNP  assembly  and
splicing defects resulting therefrom may also play a role in the degeneration of motor
neurons in spinal muscular atrophy (SMA) patients (Boulisfane et  al., 2011). Minor
spliceosome components are also essential for development in Arabidopsis thaliana, D.
melanogaster, and Danio rerio (Otake et al., 2002; Kim et al., 2010; Pessa et al., 2010;
Markmiller et al., 2014).
Table 1. Human integral spliceosomal snRNP proteins.
U1 U2 U5 U4/U6
U4atac/U6atac
U4/U6.U5
U4atac/U6atac.U5
U11/U12 Yeast
homolog
Functions Selected references
Sm1 Sm1 Sm1 Sm1 Sm1 Sm1 Sm1 snRNP core components Pomeranz Krummel et
al. (2009)
Lsm2 Lsm2 Lsm2 snRNP core components Zhou et al. (2014)
U1-70K Snp1 Structural; SR protein
interactions
Cho et al. (2011)
U1A Mud1 Structural; RNA-binding Pomeranz Krummel et
al. (2009)
U1C Yhc1 5ʹss recognition Pomeranz Krummel et
al. (2009)
U2Aʹ Lea1 Structural; RNA-binding Price et al. (1998)
U2Bʺ Msl1 Structural; RNA-binding Price et al. (1998)
SF3a3 SF3a3 BPS binding Gozani et al. (1996)
SF3b3 SF3b3 SF3b3 BPS binding Gozani et al. (1996); Will
et al. (1999)
PRP43 PRP43 Prp43 Disassembly factor,
proofreading
Will et al. (2004); Mayas
et al. (2010)
220K 220K Prp8 Stabilization of catalytic core,
contacts many spliceosomal
and pre-mRNA sites
Pena et al. (2008); Galej
et al. (2013)
200K 200K Brr2 RNA helicase, unwinding of
U4/U6
Santos et al. (2012)
116K 116K Snu114 GTPase Small et al. (2006)
102K 102K Prp6 Tri-snRNP bridging Schneider et al. (2010a)
100K 100K Prp28 RNA helicase, exchange of U1
with U6 at 5ʹss
Staley and Guthrie
(1999)
52K Snu40 Tri-snRNP assembly Laggerbauer et al.
(1998)
40K 40K - Structural Achsel et al. (1998)
15K 15K Dib1 Structural Laggerbauer et al.
(1998)
90K 90K Prp3 Tri-snRNP bridging Horowitz et al. (1997)
61K 61K Prp31 Tri-snRNP bridging Schneider et al. (2010a)
60K 60K Prp4 Kinase, tri-snRNP entry into
spliceosome
Schneider et al. (2010a)
20K 20K CypH Peptidyl-prolyl cis/trans
isomerase
Teigelkamp et al. (1998)
15.5K 15.5K Snu13 Tri-snRNP bridging Nottrott et al. (2002)
110K Snu66 Recruitment of tri-snRNP to
the spliceosome
Makarova et al. (2001);
Schneider et al. (2002)
65K Sad1 Recruitment of tri-snRNP to
the spliceosome
Makarova et al. (2001);
Schneider et al. (2002)
27K - Recruitment of tri-snRNP to
the spliceosome
Fetzer et al. (1997)
65K - Structural, binds U12 snRNA Benecke et al. (2005)
59K - Structural, binds 48K and 65K Benecke et al. (2005);
Turunen et al. (2008)
48K - 5ʹss recognition Turunen et al. (2008)
35K - SR protein interactions,
homology to U1-70K
Lorković et al. (2004)
31K - Unknown; RNA-binding Kim et al. (2010)
25K - Unknown
20K - Unknown; homology to U1C Will et al. (2004)
Urp - 3ʹss recognition Shen et al. (2010)
After Will et al. (2004); Will and Lührmann (2011); and Turunen et al. (2013a).
1Sm proteins B/Bʹ, D1, D2, D3, E, F and G.
2Lsm2-8.
3Multisubunit complexes.
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1.3 SPLICEOSOME ASSEMBLY AND CATALYSIS
1.3.1 Splicing catalysis
Pre-mRNA splicing is achieved by two consecutive transesterification reactions
(reviewed by Valadkhan and Jaladat, 2010), the first step being the nucleophilic attack
of the 2ʹ hydroxyl group of the branch point nucleotide on the phosphate group at the
5ʹ splice site. As a result, the upstream exon is left with a free 3ʹ hydroxyl group, and
the intron together with 3ʹ exon forms a looped structure known as the lariat
intermediate. The liberated 3ʹ hydroxyl group at 5ʹss then performs the second
nucleophilic attack on the 3ʹss phosphate group, resulting in the ligation of the two
exons and the release of the excised intron as a lariat. As such, the reaction is
energetically neutral, but ATP is required in many proofreading and rearrangement
steps during spliceosome assembly. A similar two-step reaction mechanism is
employed by both spliceosomes and also by group II self-splicing introns (Lambowitz
and Zimmerly, 2011).
As self-splicing introns are capable of splicing catalysis without the help of proteins, it
has been a long-standing belief that the spliceosomal catalysis, too, is performed by
RNA. U6 snRNA, the most conserved snRNA component of the spliceosome (Guthrie
and Patterson, 1988), resides at the catalytic center of the spliceosome and
coordinates the catalytic Mg2+ ions (Yean et  al., 2000; Fica et  al., 2013). Even more
concrete evidence for snRNA catalysis comes from the observations that U2 and U6
snRNAs can catalyze a two-step splicing-like reaction in the absence of proteins
(Valadkhan and Manley, 2001). Furthermore, with the minor spliceosome it has been
shown that replacing the U6atac stem-loop structure with a group II intron domain D5
stem-loop, which is also involved in coordination of divalent cations in the catalysis of
self-splicing introns, supports splicing of U12-type introns (Shukla and Padgett, 2002).
In addition to snRNAs, the Prp8 protein of the U5 snRNP has been, for a long time, the
other candidate for catalysis, as it makes many contacts within the catalytic core,
including U6, U5, 5ʹss, 3ʹss, and the branch point (reviewed by Abelson, 2008).
However, in a recent crystal structure of Prp8, it was shown that critical residues of the
protein, corresponding to active site residues of a related protein fold, do not
coordinate magnesium and are thus unable to perform catalysis (Galej et al., 2013).
Still, it is clear that Prp8 has important functions in the positioning of the substrate and
snRNPs (Pena et al., 2008), and numerous protein components are necessary to
perform splicing efficiently and precisely in vivo.
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1.3.2 Assembly of the U2-dependent spliceosome
Spliceosome assembly has been studied extensively in vitro.  It  is  assembled  by  the
stepwise addition of the spliceosomal snRNPs onto the splicing substrate (see Figure 3).
Using biochemical methods, assembly intermediates have been observed and are
usually labeled E, A, B, Bact, B*, and C complexes, in the order of appearance (reviewed
by Will and Lührmann, 2011).
The assembly pathway begins with the association of the U1 snRNP with the 5ʹ splice
site and the U2AF protein dimer with the 3ʹ end of the intron (Zhuang and Weiner,
1986; Zamore and Green, 1991). U1 snRNA base-pairs with the 5ʹss, and the interaction
is stabilized by protein-RNA interactions, especially by the U1C protein (Heinrichs et al.,
1990; Du and Rosbash, 2002; Pomeranz Krummel et al.,  2009).  At  the  same  time,
protein factors SF1 (splicing factor 1) and U2AF recognize the branch point sequence
and the 3ʹ end of the intron, respectively (Berglund et al., 1997; Liu et al., 2001). The
branch point A residue used as the nucleophile in the first catalytic step is already
recognized and bulged out by the SF1 (Liu et al.,  2001).  The  65K  subunit  of  U2AF  is
responsible for binding to the polypyrimidine tract while the 35K subunit binds to the
3ʹss (Zamore and Green, 1991; Guth et al., 1999; Wu et al., 1999; Zorio and Blumenthal,
1999). These interactions constitute the early (E), or commitment complex.
Prespliceosome,  or  A  complex,  emerges  when  U2  snRNP  displaces  SF1  at  the  branch
point (Bindereif and Green, 1987). U2 is already present in the E complex in close
proximity to U1, but remains loosely associated (Das et al., 2000; Dönmez et al., 2007).
ATP is needed for the stable binding of U2 snRNP but this requirement is relaxed when
the 5ʹ end of U1 is mutated, or when a checkpoint protein Cus2 is deleted, suggesting
that some rearrangement is necessary to accommodate U2 stably (Liao et al., 1992;
Perriman and Ares, 2000). U2AF65 binds to the polypyrimidine tract and with the help
of its RS domain recruits U2 snRNP via the SF3b complex (Valcárcel et al., 1996; Gozani
et al., 1998; Selenko et al., 2003; Spadaccini et al., 2006). U2 snRNA base pairs with the
branch point sequence (Wu and Manley, 1989; Zhuang and Weiner, 1989). The same
branch point adenosine that was already recognized by SF1 (see above) is also bulged
out from the U2/BPS base-pairing helix (Parker et al., 1987; Query et al., 1994).
In the next step of assembly, U4/U6.U5 tri-snRNP enters the nascent spliceosome,
forming the precatalytic B complex. Rearrangements of base-pairing helices follow,
transforming the spliceosome to the activated Bact complex. In these rearrangements,
new base-pairing interactions are formed between U6 snRNA and 5ʹss, and the
interaction between U1 and 5ʹss is unwound by the action of Prp28 helicase (U5-100K
in humans; Kandels-Lewis and Séraphin, 1993; Staley and Guthrie, 1999). Similarly U4
unwinds from U6, catalyzed by the Brr2 (U5-200K) helicase (Konarska and Sharp, 1987;
Wassarman and Steitz, 1992a; Raghunathan and Guthrie, 1998; Mozaffari-Jovin et al.,
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2012; Santos et al., 2012). As a consequence, U2 snRNA base-pairs with U6 (Hausner et
al., 1990; Wu and Manley, 1991; Madhani and Guthrie, 1992), which requires
rearrangements of the internal stem loops of both snRNAs (reviewed in Staley and
Guthrie, 1998). A “catalytic core” structure is formed, where U2 and U6 snRNA bound
together also bind to the BPS and 5ʹss, thus bringing them close in space for the ﬁrst
step of the catalysis (Burke et  al., 2012). U5 helps to align the exons for accurate
cleavage  (Newman  and  Norman,  1991;  Sontheimer  and  Steitz,  1993).  Significant
remodeling of spliceosomal protein content also occurs during B complex activation,
with U1 and U4-associated proteins leaving and a considerable number of proteins
joining,  including  the  Prp19/CDC5  complex  (abbreviated  19C  or  NTC;  Makarov et al.,
2002; Bessonov et al., 2008; Fabrizio et al., 2009; Agafonov et al., 2011). Consequently,
the Bact complex is converted to the catalytically active spliceosome (B*) by the
DExH/D-box helicase Prp2 which remodels the active site by removing SF3a and SF3b
complexes and exposing the branch point adenosine (Warkocki et al., 2009; Lardelli et
al.,  2010;  but  see  also  Wlodaver  and  Staley,  2014).  The  first  step  of  splicing  is  then
performed. Further conformational changes, assisted by helicases and peptidyl-prolyl
cis/trans isomerases, accompany the progress to complex C, which catalyses the
second transesterification step.
After the splicing reaction has taken place, the postcatalytic complex is disassembled,
releasing ligated exons and a lariat intron, which still retains U2, U6 and U5 snRNPs.
These, along with other spliceosomal components, are recycled for the next splicing
reaction (Tsai et al.,  2005).  Recycling  factors,  such  as  Prp43,  can  also  be  used for  the
rejection of suboptimal splicing intermediates, improving the fidelity of the reaction
(Mayas et al., 2010).
1.3.3 Intron recognition by the U12-dependent spliceosome
The overall assembly pathway of the U12-dependent spliceosome is likely to resemble
the major splicing pathway (Turunen et al., 2013a). However, a fundamental difference
exists in the recognition and commitment of splice sites. No commitment complex can
be detected on minor introns, and protein factors U2AF and SF1 do not participate in
their recognition. Instead, the 5ʹ splice site and branch point sequences are recognized
cooperatively by the pre-formed U11/U12 di-snRNP (Tarn and Steitz, 1996b; Frilander
and Steitz, 1999). Analogously to the major spliceosome, the 5ʹ splice site is recognized
by U11 snRNA through sequence-specific base-pairing, but the base-pairing spans only
nucleotides +4 to +8 compared to U2-type interaction spanning the exon-intron
junction (Kolossova and Padgett, 1997; Yu and Steitz, 1997). A protein component
unique to the minor spliceosome, U11-48K, recognizes the first three nucleotides of
the intron (Turunen et  al., 2008; Tidow et al., 2009). U12 snRNA performs the same
function as the U2 snRNA in the major spliceosome in recognizing and base-pairing
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with the BPS, and bulging out the branch site A residue for the first step of catalysis
(Hall and Padgett, 1996; Tarn and Steitz, 1996b). The 3ʹ splice site is initially bound by
the Urp protein, a protein component of the U11/U12 di-snRNP, which is related to
U2AF35 and required for both U12 and U2-dependent splicing pathways, but,
interestingly, at different stages of spliceosome assembly (Will et al., 2004; Shen et al.,
2010).
The higher splice site sequence conservation, the lack of the polypyrimidine tract, and
the non-involvement of U2AF imply that initial intron recognition by the U12-
dependent spliceosome relies more on sequence-specific snRNA-mRNA interactions
than the major type spliceosome (Brock et al., 2008). Still, exon definition interactions,
assisted by protein splicing factors, are important also for the U12-dependent splicing
(Hastings and Krainer, 2001).
Review of the literature 18
Figure 3. Assembly pathways of the U2-dependent and U12-dependent spliceosomes. Adapted
with modifications from Turunen et al. (2013a). See text for details. Question mark reflects that
the association of the Nineteen complex (19C) to the U12-dependent spliceosome has not been
directly shown, but is inferred from the major spliceosome.
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1.3.4 Assembly of the U12-dependent spliceosome
Due to the differences in early assembly steps, described in the previous section (1.3.3),
the first splicing complex that can be detected on U12-dependent introns is the A
complex, in which the U11/U12 di-snRNP has bound the intron’s 5ʹss  and  BPS  in  a
cooperative manner (Tarn and Steitz, 1996b; Frilander and Steitz, 1999). During
prespliceosome formation, these catalytic sites are therefore brought to proximity,
implying that less rearrangements in spliceosome conformation are needed later on
(Frilander  and  Meng,  2005).  A  similar  arrangement  of  catalytic  sites  in  the  early
spliceosome has also been observed with the major spliceosome (Dönmez et al., 2007),
suggesting that the prespliceosomal architectural constraints may also be conserved
between the two spliceosomes. Consistently, overall the assembly pathways of the two
spliceosomes are thought to resemble each other remarkably well. As noted above
(section 1.2.2), the snRNA components of the U12-dependent spliceosome, although
divergent in sequence, fold into similar secondary structures, and associate with an
almost identical protein complement. Also, bulging of the reactive adenosine is
achieved analogously during base-pairing between U12 and BPS (Hall and Padgett,
1996; Tarn and Steitz, 1996b). The U4atac/U6atac/U5 tri-snRNP behaves as their major
tri-snRNP counterpart, its entry marking the formation of complex B, where U6atac
unwinds from U4atac and replaces U11 at the 5ʹ splice site (Tarn and Steitz, 1996a; Yu
and Steitz, 1997; Incorvaia and Padgett, 1998). The base-pairing that occurs between
U12 and U6atac closely resembles that between U2 and U6, and they are thought to
constitute the catalytic core in a manner similar to the major spliceosome and group II
self-splicing introns (Tarn and Steitz, 1996a; Frilander and Steitz, 2001; Shukla and
Padgett, 2001; Shukla and Padgett, 2002). It has been noted, however, that in the U12-
dependent splicing pathway, the catalytic core formed by U12/U6atac base-pairing
may appear before U11 has been released from the 5ʹ splice site, implying that
proofreading of the 5ʹ splice site is not strictly required for the formation of the
catalytic core (Frilander and Steitz, 2001). Finally, the two transesterification reactions
are identical between the two spliceosomes and yield the same final products, the
ligated exons and a lariat intron, and are likely followed by a similar disassembly
pathway and recycling of snRNPs for the next round of splicing as in the major
spliceosome (Damianov et al., 2004). It has also been noted that the U11/U12 di-
snRNP contains the disassembly factor PRP43, which in the major spliceosome
associates with U2 snRNP (Will et al., 2004).
1.4 SPLICE SITE SELECTION
1.4.1 Exon definition
As stated earlier, the structure of eukaryotic genes, particularly in vertebrates, is such
that short exons are found within long stretches of intronic sequences. Combined with
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the degeneracy of typical major type splice sites, it poses a problem for the splicing
machinery to accurately identify exons and disregard those sequences that only
resemble bona fide splice sites by chance.
The  exon  definition  hypothesis  resolves  the  difficulty  of  pairing  exons  correctly  over
long introns by postulating that the splice sites across exons are paired first, and then a
switch occurs to pair those sites that will be spliced together. The hypothesis was
formulated when it was observed that a downstream 5ʹ splice site enhanced the
splicing of an upstream intron (Robberson et al., 1990). Since then substantial evidence
has accumulated in support of the hypothesis. For instance, strengthening the 5ʹss
(leading to increased U1 binding) will enhance the binding of U2AF65 to an upstream
3ʹss (Hoffman and Grabowski, 1992). Also, terminal exons that do not have upstream
(first exon) or downstream splice sites (last exon) are enhanced by the communication
to mRNA terminal structures, the cap binding complex in the 5ʹ end and the
polyadenylation site in the 3ʹend of the transcript (Niwa and Berget, 1991; Lewis et al.,
1996). The alternative hypothesis, intron definition, has received support for those
transcripts that have relatively large exons and short introns, as is typically the case in
yeast  (Talerico  and  Berget,  1994;  Fox-Walsh et al., 2005). However, in vertebrates it
appears that the length of a typical exon is shorter than 300 nt, and one reason may be
the requirement to support exon definition interactions (Berget, 1995; Lander et al.,
2001). Further support to exon-bridging interactions playing an important role comes
from observations that steric hindrance can restrict the efficiency of snRNP binding
across very short exons (Black, 1991; Dominski and Kole, 1991).
In human hereditary diseases that involve mutations in the vicinity of splice junctions,
mutations often lead to exon skipping, but only very rarely to intron retention, arguing
for initial pairing of exons rather than introns (Krawczak et  al., 1992; Nakai and
Sakamoto,  1994).  Compensatory  evolution  of  mammalian  splice  sites  bordering  an
exon has also been detected, meaning that if one splice site next to an exon is mutated,
compensatory mutations at the other side of the exon may alleviate the splicing defect,
but no compensation occurs across introns (Xiao et al., 2007). This further implies that
exons are the mammalian evolutionary units that selection acts upon.
1.4.2 Commitment complex formation
Splice  sites  become  committed  to  splicing  at  the  E  complex  stage  of  spliceosome
assembly. Based on the early work on spliceosome assembly that has utilized minigene
constructs containing only one intron surrounded by two exons, it has been assumed
that intron definition occurs at this stage. However, in a more natural context the
spliceosome is often presented with a task of pairing many consecutive exons and a
choice of alternative splice sites (for a discussion of alternative splicing, see section
below). The choice of pairing specific splice sites has been convincingly shown to occur
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only at A complex stage (Lim and Hertel, 2004). This leaves the opportunity for
interactions to occur first across exons, committing splice sites for usage, and then
switching the interaction to pair intron ends that are to be spliced together,
committing the pairing of exons. Even more persuasively, an A-like complex containing
the tri-snRNP assembles across an exon substrate and is converted to a B-like complex
capable of splicing when offered a 5ʹ splice site oligonucleotide in trans, implying that
interactions connecting intron ends are not required for B complex formation, and that
disruption of cross-exon interactions is not required for the formation of cross-intron
interactions (Schneider et  al., 2010b). Furthermore, splicing factors that affect
alternative splicing may do so at the level of inhibiting the conversion of exon-defined
complexes into intron-bridging complexes (Sharma et al., 2008).
1.4.3 Alternative splicing
Recent transcriptome-wide surveys have revealed that the majority, a staggering 95%,
of mammalian transcripts display alternative splicing, in which the processing of a pre-
mRNA transcript results in the inclusion of different parts of that transcript in the final
mRNA product (Pan et  al., 2008; Wang et  al., 2008). Such extensive alternative
processing increases variation in the expressed proteome and provides ample
opportunity for cell-type, tissue and time point dependent regulation. When
comparing different organisms, alternative splicing is found to be most common in
mammals and particularly in primates (Barbosa-Morais et al., 2012).
Figure 4. Types of alternative splicing.
White boxes, constitutive exons; grey boxes, alternative exons. Straight lines, introns; bent lines,
splicing patterns. A, Constitutive splicing; B, Alternative 5ʹss; C, AlternaƟve 3ʹss; D, AlternaƟve
cassette exon (i.e. exon skipping or inclusion); E, Intron retention; F, Mutually exclusive exons.
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Different kinds of alternative splicing patterns exist, including alternative 5ʹ and 3ʹ
splice site usage, alternative exon skipping or inclusion (the exon in question is often
referred to as a cassette exon), intron retention, and mutually exclusive alternative
exons (see Figure 4). Of these, a large fraction of investigations have focused on
cassette exon splicing. Remarkable diversity can be achieved with such a restricted
number of categories. For instance, the Drosophila Dscam (Down  syndrome  cell
adhesion molecule) gene contains three clusters of mutually exclusive exons, the
combination of which results in over 38 000 different mRNA products and changes the
protein-protein binding specificity of Dscam (Schmucker et  al., 2000). The Dscam
adhesion molecules show homophilic binding, meaning that the products of one
isoform bind to each other but not to any other isoform type (Wojtowicz et al., 2004).
It appears that isoform choice is probabilistic (i.e. not regulated in cell-dependent or
temporal manner), and that one neuron expresses on average 4 different types (Miura
et al., 2013). In effect, the Dscam adhesion proteins provide an identity code for
individual neurons that causes the dendrites of one neuron to repel each other and
make contacts only with the dendrites of another neuron (Hattori et al., 2009).
Alternative splicing is rare in U12-type introns (Turunen et al., 2013a). Splice site
selection in the minor splicing pathway is less flexible due to longer consensus
sequences and more strict distance requirements between splicing signals (Levine and
Durbin, 2001). Exon skipping is also absent for U12-dependent introns because U12-
type introns usually occur only once in a given gene, and the splice sites are
incompatible with U2-type sites. Alternative 3ʹ splice site usage has been reported, but
may represent only splicing noise as the reported alternative 3ʹss sequences are
typically in very close proximity of the bona fide 3ʹss (Levine and Durbin, 2001; Zhu and
Brendel, 2003; Hastings et al., 2005).
The incompatibility of U12-type and U2-type splice sites is demonstrated by the
alternative splicing pattern found in the vertebrate JNK gene  family,  in  which  two
alternative mutually exclusive exons utilize the two different types of spliceosomes
(Chang et al., 2007). The splicing choice is made in a hybrid intron, which contains a
U12-type 5ʹ splice site and a U2-type 3ʹ splice site. These can only splice to the
compatible splice sites downstream or upstream, respectively. Another case of
alternative splicing involving the competition of the two spliceosomes can be found in
the Drosophila gene prospero, which codes for a protein involved in axon guidance
(Scamborova et al., 2004). This gene contains a U2 intron nested within a U12 intron, a
so-called ‘twintron’. If the U12-type sites are used for splicing instead of U2-type, the
resulting mRNA codes for a protein that lacks 29 amino acids in the homeodomain
region. A similar twintron can also be found in the Drosophila splicing factor Urp (Lin et
al., 2010).
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1.4.4 Splicing regulatory elements
Splice site signals themselves are too degenerate to contain sufficient information for
unequivocal specification of the intron/exon boundary (Burge et al., 1999). This is true
even  for  the  U12-type  splice  site  sequences  which  are  more  conserved  than  the  U2-
type sites (Burge et  al., 1999). Therefore, sequence elements termed splicing
regulatory elements (SREs) are needed to provide additional information for the
identification of correct splice sites from the abundant pseudo sites (Zhang et al., 2003).
In addition to helping in specifying constitutively spliced exons, the same elements also
regulate alternative splicing. These sequence elements are present in both exons and
introns of the transcript, and can function either as inhibitory or enhancing signals. A
sequence element can even have opposite effects on splicing, depending on its
location and other context-dependent factors (Yeo et al.,  2007).  The  effect  of  an
individual SRE is highly context-dependent and often several SREs exert a concerted
effect on a particular splicing event. Theoretically, the combinatorial evaluation of
sequence elements, collectively named the “splicing code”, on a given transcript
should predict the outcome of splice site choices for that transcript (Wang and Burge,
2008). Until recently, however, the complexity and context dependence of the splicing
code have made these predictions rather imprecise. Bioinformatic approaches
combined with tissue- and developmental stage specific splicing pattern data have
resulted in advances in compiling a splicing code that can be used to predict splicing
outcome for cassette exons with improved probability (Barash et  al., 2010; Barbosa-
Morais et al., 2012). However, for splicing choices other than alternative cassette
exons, such combinatorial understanding is still missing.
1.4.5 Splicing factors
The SREs described in the previous section mostly function by recruiting trans-acting
factors  that  aid  in  the  selection  of  splice  sites  or  assembly  of  the  spliceosome.  The
splicing factors perform this task by binding to their SREs via RNA-binding domains,
such as RNA recognition motifs (RRMs), hnRNPK homology domains (KH) and zinc-
finger domains (Castello et al., 2012). Subsequently they recruit spliceosome
components to the nascent transcripts via association to the Pol II (Das et al., 2007),
acting positively by stabilizing interactions between spliceosome components and the
pre-mRNA  or  other  splicing  factors  (Fu  and  Maniatis,  1992;  Boukis et al., 2004), or
negatively by blocking such interactions (Kanopka et al.,  1996;  McNally  and  McNally,
1996). Splicing factors are important in both constitutive and alternative splicing (Wu
and Maniatis, 1993; Zhang et al., 2003). The best known splicing regulatory factors are
the proteins belonging to SR (serine-arginine rich) and hnRNP (heterogeneous nuclear
RNP) protein families. Originally identified as positive and negative regulators of
splicing, respectively,  it  is  now known that their effect on a particular splicing event is
heavily context-dependent (Witten and Ule, 2011).
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SR splicing factors typically contain one or two RRM domains and an arginine-serine
(RS) rich domain (Manley and Krainer, 2010). The SR family comprises twelve proteins
including some of the originally described and well-studied members, SRSF1 and SRSF2
(previously  known  as  SF2/ASF  and  SC35,  respectively).  There  are  also  SR  proteins
without RNA recognition domains that can link other SR proteins bound on the RNA
(Boucher et  al., 2001). Other SR-like proteins include a number of more intregral
spliceosomal proteins, for instance U1-70K, which enhances the binding of U1 snRNP
to the 5ʹ splice site (Kohtz et al., 1994; Cho et al., 2011), U2AF proteins and Urp, which
interact with the 3ʹ splice site (Shen et al.,  2010),  and SR proteins that are involved in
recruiting the U4/U6.U5 tri-snRNP to the spliceosome (Roscigno and Garcia-Blanco,
1995; Makarova et  al., 2001). Interestingly, SR proteins have functions that range
beyond splicing regulation and are now recognized to act also in chromatin remodeling,
mRNA export, miRNA processing, translation, and mRNA decay (reviewed by Twyffels
et al., 2011; Änkö, 2014).
The RRM domains found in SR proteins function by binding to single-stranded RNA
while the RS domain typically participates in protein-protein interactions (Mayeda et
al.,  1992).  The  length  of  the  RS  domain,  or  more  specifically,  the  number  of  RS
dipeptide repeats, correlates with the strength of activation (Philipps et al., 2003). The
serine residues in the RS domain can be phosphorylated and this modulates the
activity of the SR protein, and ultimately, provides the means to decode transduction
pathway signals to alternative splicing outcomes (Lynch, 2007). For example,
phosphorylation of the RS domain can alter the conformation of a SR protein; the
unphosphorylated RS domain of SRSF1 is involved in intramolecular interactions to the
RRM domain of the same protein, while phosphorylation leads to an open
conformation and a switch to intermolecular interactions with the RRM of U1-70K,
required for the formation of the E complex (Cho et al., 2011).
HnRNP proteins, like the SR proteins, display a modular structure of RNA-binding
domains. They bind to many kinds of RNA and single-stranded DNA sequences, with
binding interactions described with mRNAs, miRNAs, and telomerase RNA, but with a
particular preference for intronic sequences. They participate in the packaging of
nuclear mRNAs and regulate their processing and export, and also shuttle to cytoplasm
where they regulate the translation and localization of mRNAs (Han et al., 2010). Their
most studied function is to regulate alternative splicing (Huelga et  al., 2012). For
instance, hnRNP A1, which is one of the best characterized members of the hnRNP
group, often antagonizes the effect of SR proteins in splicing regulation. HnRNP C, on
the other hand, is involved in the packaging of the majority of nuclear pre-mRNAs and
packs the intronic RNA around protein tetramers, much reminiscent of DNA
nucleosomes (Huang et al., 1994; König et al.,  2010).  In  doing  so  it  may  affect  the
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choice of splice sites, and indeed, hnRNP proteins also have context-dependent
influences on alternative exons, resulting in either enhanced inclusion or silencing
(Blanchette et al., 2009).
Splicing factors involved in U2-type splicing are also required in the U12-dependent
pathway, where they are involved in exon definition interactions between
spliceosomes and also contact the pre-mRNA directly (Wu and Krainer, 1996; Hastings
and Krainer, 2001; Shen and Green, 2007). Both SR proteins and hnRNP proteins have
been shown to occupy binding sites in U12-type intron-containing transcripts that
affect the efficiency of splicing (Lewandowska et al., 2004; McNally et al., 2006; Borah
et al., 2009). In addition, the minor spliceosome specific protein U11-35K has a similar
domain structure to U1-70K, including an N-terminal RRM domain and a C-terminal RS
domain, suggesting that it is involved in stabilization of 5ʹ splice site interaction and/or
bridging interactions (Will et al., 1999; Lorković et al., 2004). Importantly, since there
are usually only one, and rarely two or three, U12-type introns in a given transcript in
conjunction with several U2-type introns, the U12-dependent spliceosome must be
able to form compatible exon definition interactions with the major type spliceosome
for efficient processing.
1.4.6 SnRNPs as processing factors
In addition to splicing regulatory proteins, core spliceosomal components can also
have a role in splice site selection that is more complex than a mere binding to the
splice sites. The levels of several core spliceosomal proteins, including U1, U2, and
U4/U6 snRNP-associated proteins, have been shown to affect the outcome of splicing
with Drosophila transcripts (Park et al., 2004). In human cells, the depletion of SmB/B’
has been shown to change alternative splicing outcomes (Saltzman et al., 2011). A
U1C-deficient zebrafish retains a surprisingly high level of functional splicing but shows
misregulation of alternative splicing patterns (Rösel et al., 2011). These experiments
suggest that the levels or activity of key snRNP proteins affect the intron recognition
process, especially for weak splice sites.
Binding of snRNPs to pseudo U2-type 5ʹ splice sites that do not function as splicing
donor sites can cause splicing inhibition and these pseudo sites can have alternative
roles both as exonic and intronic splicing silencers, as suggested by large-scale screens
for SREs (Wang et al., 2004; Yeo et al., 2007). For example, U1 snRNP, when bound to
an exonic pseudo splice site, has been shown to inhibit the recognition of a close-by
bona fide splice site, possibly by direct steric hindrance or by destabilization of the
binding of other splicing components (Cunningham et  al., 1991; Siebel et  al., 1992;
Cloutier et  al., 2008). In Rous sarcoma virus such unproductive binding of U1 snRNP
has been harnessed to suppress all splicing of the pre-mRNA, which is necessary for the
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formation of viral genomic RNAs during the retroviral lifecycle (McNally and McNally,
1999).
In addition to U2-type splicing signals, also U12-type sequences, particularly the 5ʹss
consensus sequence but also U12-type BPS and 3ʹss sequences, were discovered in the
above-mentioned SRE screens (Yeo et al., 2007). Remarkably, deletion of a functional
U1 snRNP binding site that represses a pseudoexon inclusion can be rescued by U11
snRNP binding site in an in vitro splicing reaction (Dhir et al., 2010). This supports the
notion that exon definition interactions between the two spliceosomes are similar and
often interexchangable.
Interestingly, U1 snRNP binding sites can also act as splicing enhancers. G nucleotide
triplets are enriched in the vicinity of genuine exons and can bind U1 snRNP directly,
and their deletion can be rescued by replacing them with 5ʹss consensus sequences
(McCullough and Berget, 2000). In another example, U1 snRNP binding enhances the
use of cryptic upstream 3ʹss in U1-70K mRNA (see section 1.6.7; Rösel-Hillgärtner et al.,
2013).  SREs  recognized  by  snRNPs  can  recruit  other  spliceosomal  snRNPs  and,
remarkably, even induce assembly of complete spliceosome-like complexes (Giles and
Beemon, 2005; Dhir et  al., 2010). Importantly, these complexes differ from genuine
assembly intermediates either in composition or conformation, as they do not activate
splicing but instead form dead-end complexes.
U1 snRNP extends its influence on the mRNA processing pathway even further at the
level of polyadenylation. Evidence of this was first discovered with the observation that
the U1A protein can bind to the 3ʹUTR of its own mRNA and inhibit polyadenylation
(Boelens et al., 1993; Gunderson et al., 1994). U1 can also bind to intronic pseudo 5ʹss
sequences and suppress premature cleavage and polyadenylation, which would
otherwise lead to formation of truncated transcripts. In fact there is a need for such
machinery as the polyadenylation signal (AAUAAA or AUUAAA and their variants)
occurs  on  average  every  2000  nt  at  genomic  scale.  This  mechanism  is  most  likely
ubiquitous, working at the level of the whole transcriptome (Kaida et al., 2010).
1.4.7 Other factors affecting alternative splicing
A number of other aspects can also influence splice site selection. For instance, pre-
mRNA folding may bring distant splice sites closer together in space and so enhance
their pairing (Charpentier and Rosbash, 1996). Pre-mRNA secondary structure may also
sequester splice sites and lead to the exclusion of cassette exons (Clouet d'Orval et al.,
1991). In the Drosophila Dscam gene, which can form up to 38 000 different splice
variants (see section 1.4.3), alternative cassette selection occurs after the formation of
secondary structure between docking and selector sequences surrounding alternative
cassette exons. This mechanism ensures that only one of the many alternative cassette
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exons is included in the mRNA (Graveley, 2005). In other instances intronic secondary
structure elements may even function as riboswitches that bind to small molecule
metabolites and activate or repress splicing in response to the concentration of the
metabolite (Cheah et al., 2007).
Additionally, a substantial amount of evidence has accumulated demonstrating that
transcription rate and chromatin structure can affect alternative splicing. This topic will
be discussed in the following section.
1.5 INTERCONNECTIVITY IN NUCLEAR RNA-PROCESSING PATHWAYS
1.5.1 Cotranscriptional processing of pre-mRNA
Pre-mRNA molecules are transcribed from the chromatin template by RNA polymerase
II. The transcription cycle goes through preinitiation, initiation, promoter clearance,
promoter-proximal pausing, elongation, and termination steps. A pre-initiation
complex containing general transcription factors and a hypophosphorylated Pol II
assembles on the promoter, followed by opening of the DNA duplex at the promoter
(“promoter melting”), RNA phosphodiester bond formation and the transit of Pol II
away from promoter (“promoter clearance”).
Progression through the consecutive steps is regulated via the reversible
phosphorylation of the C-terminal domain (CTD) of Rbp1, the largest subunit of Pol II.
The CTD is a tail-like extension consisting of up to 52 repeats of the heptapeptide
sequence YSPTSPS (reviewed by Lenasi and Barboric, 2013). During initiation and early
elongation, mainly Ser5 is phosphorylated (Komarnitsky et al., 2000). This is needed for
the association of processing factors,  and processing begins as soon as the pre-mRNA
emerges from the RNA polymerase, due to the targeting of capping enzymes to the
CTD (McCracken et al., 1997a; Schwer and Shuman, 2011). Later during elongation,
phosphorylation emphasis switches to Ser2, and cleavage and polyadenylation factors
are recruited, leading to transcription termination and release of the newly
synthesized transcript (McCracken et  al., 1997b). Thus, the CTD functions as an
organization hub or a ”landing pad” for many processing factors, and its
phosphorylation status controls the affinity of different processing factors, ensuring
timely recruitment.
The nascent transcripts go through numerous processing steps before they are ready
to leave the nucleus, including the above-mentioned capping, cleavage and
polyadenylation, and also splicing, editing or other mRNA modifications. Once the
mRNA has matured through these processing steps, it is translocated through the
nuclear pore to the cytoplasm. While many of these processes have been studied
extensively using various in vitro systems, typically in isolation, it is important to bear
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in mind that in the nucleus they occur in close proximity and often concurrently
(reviewed by Lee and Tarn, 2013).
Nuclear contents are not uniformly distributed; instead, the nucleus contains different
microenvironments. Areas of transcriptional repression, known as heterochromatin,
tend to localize to nuclear periphery in complex eukaryotes, whereas areas of active
transcription, euchromatin, tend to localize to the interior, with channels of active
chromatin linking to the nuclear pores (reviewed by Carmo-Fonseca and Carvalho,
2007). In yeast, however, the situation is reversed, and association of active chromatin
with  nuclear  pores  is  a  more  preferred  arrangement  (Casolari et al., 2004). Distinct
nuclear bodies, including nucleoli, speckles, paraspeckles, Cajal bodies, histone locus
bodies, nuclear stress bodies and promyelocytic leukemia bodies, can also be
visualized with high resolution microscopy (reviewed by Dundr and Misteli, 2010).
These bodies are thought to facilitate nuclear events by locally increasing the
concentration of essential components, and by coordinating separate steps. They are
highly dynamic in the sense that components are constantly entering and leaving the
compartment, and are thought to form stochastically due to the self-associative
properties of the components involved (Hebert and Matera, 2000; Kaiser et al., 2008).
The relationship of transcription and splicing with these nuclear compartments is still
somewhat under debate, as the structures are not unambiguously defined. Speckle
cores, also known as interchromatin granules, are devoid of active transcription and
thus represent sites of snRNP and splicing factor storage and recycling (Misteli and
Spector, 1997; Spector and Lamond, 2011). Nascent RNAs are located to the periphery
of  speckles  in  areas  called  perichromatin  fibrils  (PFs),  and  snRNPs  and splicing  factors
move away from speckles to PFs to perform splicing. High transcriptional activity at a
chromatin  locus  can  also  attract  a  large  number  of  snRNPs,  which  can  appear  as  a
speckle-like body under the microscope, or active chromatin can loop in such a manner
that it overlaps with the speckle (Han et al., 2011). Furthermore, a subset of introns
can splice post-transcriptionally (see section 1.5.2), and this may cause some
transcripts to localize to the vicinity of speckles for completion of splicing.
1.5.2 Cotranscriptionality of splicing
Several interdependencies between transcription and splicing have been described.
For a long time it has been known that pre-mRNAs subjected to splicing are associated
with chromatin, which suggested that processing steps can occur co-transcriptionally
(Baurén and Wieslander, 1994). As truncation of the RNA polymerase CTD leads to the
inhibition of splicing (McCracken et al., 1997a), it was conceivable that processing
factors, including spliceosome components and SR proteins, can be recruited to the
nascent transcript via interactions with the CTD (Mortillaro et al., 1996; Kim et  al.,
1997). Consistently, it has been shown that U2AF65 copurifies with the CTD and
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crosslinks to the very first nucleotides of the nascent RNA emerging from the
polymerase (Robert et al., 2002; Ujvári and Luse, 2004). Furthermore, the presence of
hyperphosphorylated CTD enhances spliceosome complex assembly (Hirose et al.,
1999). Finally, positive feedback with recruitment of splicing factors to the
transcription machinery has been described, so that the presence of introns in pre-
mRNA stimulated pre-mRNA synthesis (Brinster et  al., 1988; Furger et al., 2002;
Damgaard et al., 2008). Reciprocally, inhibition of splicing with spliceostatin A, which
binds to SF3b inhibiting branch point recognition by U2 snRNP, leads to inhibition of
transcription elongation, suggesting a close cooperativity between elongation and
processing (Koga et al., 2014).
The recruitment of splicing factors to CTD is largely dependent on the presence of
introns in the pre-mRNA. Chromatin immunoprecipitation (ChIP) experiments have
revealed that while recruitment of splicing factors takes place cotranscriptionally for
transcripts containing introns, such recruitment is not observed with intronless
transcripts (Görnemann et  al., 2005; Listerman et  al., 2006; Moore et al., 2006). An
exception to this is U2AF65, which has been observed to be recruited also to intronless
genes (Görnemann et al., 2005). As the detected interactions are sensitive to RNase
treatment (Moore et al., 2006), it seems that the CTD does not directly recruit splicing
factors, but requires concomitant interaction with introns.
It is likely that the majority of splicing is cotranscriptional. Splicing kinetics of newly
synthesized pre-mRNAs have been mapped using quantitative PCR (qPCR) and, more
recently, with RNAseq (Singh and Padgett, 2009; Khodor et  al., 2011), which both
reveal that splicing takes place while transcription is ongoing, and that spliced mRNAs
associate with the chromatin fraction during cellular fractionation (Pandya-Jones and
Black, 2009). Furthermore, the localization of the splicing process has been also
investigated using immunological (Girard et al., 2012) and single-molecule techniques
(Vargas et al., 2011). These works readily confirm that the majority, but not all, splicing
is cotranscriptional. While most of this data arises from studies concentrating on U2-
type introns, essentially the same conclusions have been confirmed with U12-type
introns as well (Singh and Padgett, 2009). Given that both types of spliceosomes share
most of their protein components, and interact with the same protein components
known to associate with the CTD (such as SR proteins), this conclusion is hardly
surprising. This general conclusion has been challenged in a study claiming a
cytoplasmic localization for U12-dependent spliceosome (König et al., 2007). However,
subsequent studies on the localization of the minor spliceosome and splicing of U12-
type introns, and the demonstration of cotranscriptional nature of the splicing of minor
introns, have refuted this single claim and demonstrated that on this level both
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spliceosomes function similarly (Friend et  al., 2008; Pessa et  al., 2008; Singh and
Padgett, 2009).
While there is a consensus that splicing is mostly cotranscriptional, there is also
evidence of post-transcriptional splicing. For example, there are conflicting reports
concerning yeast, finding either that the majority of transcripts are cotranscriptionally
spliced (Carrillo Oesterreich et al., 2010), or that transcription is finished before
splicing completes, especially in genes whose last exons are shorter than 1 kb (Tardiff
et al., 2006). Similarly, it has been suggested that in mammalian cells at least some of
the introns, particularly those that are alternatively spliced, can be spliced post-
transcriptionally (Vargas et al., 2011; Tilgner et al., 2012).
Cotranscriptionality of splicing is also underscored by the results that link transcription
elongation rate to the choice of alternative splice sites. In constitutive splicing there is
a  general  tendency  to  follow  a  “first  come,  first  served”  principle,  so  that  the  first
intron to emerge from the RNA polymerase is engaged by splicing factors first (Beyer
and Osheim, 1988). However, this is not always the case, and the order of removal may
instead reflect the rate of intron recognition or exon definition (Kessler et al., 1993). It
has been observed that pausing or slowly elongating RNA polymerase II mutants affect
the inclusion of cassette exons (Roberts et  al., 1998; de la Mata et al., 2003). Slow
elongation favors the use of weak splice sites, because at a slow elongation rate there
is  more  time  for  spliceosome  assembly  before  a  strong  site  emerges  from  the  RNA
polymerase.
Analogously, the chromatin landscape that affects the rate of elongation also has an
impact on splicing. Chromatin remodeling by the SWI/SNF complex affects alternative
exon choice (Batsché et  al., 2006). Global relaxation of chromatin structure after
concerted histone acetylation causes relocation of splicing factors to nuclear speckles
away from chromatin (Schor et al., 2012). Spliceosome components may be recruited
directly to the chromatin via, for instance, the H3K4me3-recognizing chromodomain
protein  CHD1  (Sims et al., 2007). Interestingly, the influences seem to work in both
directions – H3K36me3 histone methylation marks and the positioning of nucleosomes
localize preferentially to exons instead of introns (Kolasinska-Zwierz et  al., 2009;
Tilgner et al., 2009). It is not yet known whether exon-enriched chromatin marks are
deposited as a result of splicing activity, or whether splicing is regulated by pre-
deposited chromatin marks. The latter view is supported by the observation that even
non-transcribed genes retain exon-enriched marks (Tilgner et al., 2009); on the other
hand, no mechanism has yet been proposed that would explain the circular argument
of regulating splicing with chromatin marks and chromatin marks with splicing.
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1.5.3 Kinetics of splicing and export
The removal rate of different introns on a given transcript can vary, and some introns
are retained even after transcription has completed and cleavage and polyadenylation
have occurred. In general, splicing rate is modulated by the strength of splice sites and
presence or absence of splicing enhancers (Hertel and Maniatis, 1998; Hicks et al.,
2010). In the case of U2-dependent splicing, the snRNPs have been shown to diffuse
freely in the nucleoplasm, and therefore their availability does not restrict the rate of
splicing (Rino et al., 2007). Neither are differences in splicing rate explained by the
binding rates of snRNPs (U1, U2, U5 or the NTC) onto yeast pre-mRNA (Shcherbakova
et al., 2013). As stated above, alternative splicing is especially prone to delayed splicing
(Vargas et al., 2011). Still, unspliced introns typically remain associated with chromatin
in a DNA-dependent manner, and are released to the nucleoplasm only after splicing is
completed (Pandya-Jones et al., 2013). However, unspliced transcripts may also be
retained at the nuclear pore, but this has only been observed in yeast (Legrain and
Rosbash, 1989; Dziembowski et al., 2004). After release from chromatin, export to the
cytoplasm is efficient in mammals (Custódio et  al., 1999; Audibert et al., 2002).
Therefore, splicing rate is typically a major determinant of how quickly an induced
transcript is available for the translation machinery, if there are no other regulatory
steps causing delays (i.e. mRNA intracellular localization or silencing at the
translational level).
Analysis of a subset of U12-type introns has revealed that these introns are often
processed more slowly than the major introns. In vitro splicing experiments revealed at
least three to five-fold reduction in the rate of splicing compared to major introns
(Tarn and Steitz, 1996b; Frilander and Steitz, 1999). This observation is supported by in
vivo experiments that also showed slower accumulation of spliced products both with
a reporter construct containing U12- and U2-type introns in the same context, and
with endogenous genes (Patel et al., 2002). Similar results were obtained with
quantification of transcription and splicing kinetics by RT-qPCR (Singh and Padgett,
2009). Furthermore, in vivo experiments on the steady state situation also reveal that
U12-type introns remain partially unspliced, both in the case of splicing reporters and
with endogenous U12-type introns (Bozzoni et al., 1984; Santoro et al., 1994; Patel et
al., 2002; Pessa et al., 2006). Finally, it has been found that the presence of a U12-type
intron can lead to reduction in the amount of protein produced, as described with pre-
mRNA injected to Xenopus oocytes (Bozzoni et  al., 1984). Conversely, protein yields
from a reporter have been reported to increase 6 to 8-fold when a U12-type intron
was changed to U2-type (Patel et al., 2002).
The mechanistic reasons for the slower rate of splicing are currently unknown.
Although minor spliceosome components are approximately 100-fold less abundant in
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the nucleus, this is not the limiting factor as splicing efficiency increases linearly with
increasing transfection efficiency of an exogenous reporter (Patel et al., 2002). Neither
does an additional 10-fold reduction in U4atac levels further impair splicing efficiency
for endogenous introns (Pessa et al., 2006). Spliceosome assembly may be less flexible
in the U12-dependent spliceosome, given that the intron recognition occurs
cooperatively (Frilander and Steitz, 1999). Alternatively, tri-snRNP recruitment may
also be a rate-limiting step, as the tri-snRNP proteins are shared between major and
minor tri-snRNPs, so unproductive recruitment of major tri-snRNP to the U12-
dependent spliceosome may occur (Schneider et al., 2002).
Regardless of the underlying mechanism, the slow removal of U12-dependent introns
has been proposed to constitute a rate-limiting step in the processing of transcripts
containing these introns (Patel et al., 2002). In the cellular context, this represents a
point of regulation whereby the expression of U12-type intron-containing genes could
be regulated by modulating the efficiency of splicing. For example, it is known that
several protein kinase inhibitors and histone acetyltransferase and deacetyalse
inhibitors have an inhibitory effect on splicing (Parker and Steitz, 1997; Kuhn et al.,
2009). Similarly, it has been also shown that signaling via the stress-activated p38MAPK
pathway can regulate U6atac expression levels, suggesting that the splicing of U12-
type introns may be connected to cellular growth conditions (Younis et al., 2013).
Regulation of gene expression by U12-dependent spliceosome could explain why a
parallel spliceosome is maintained in many eukaryotic genomes. This hypothesis is
supported by the conservation of U12-type introns in certain gene families, and more
strikingly, the presence of U12-type introns in nonhomologous positions in paralogous
genes (Burge et al., 1998).
1.6 RNA QUALITY CONTROL
1.6.1 Nuclear quality control
Pre-mRNA processing in the nucleus is inherently noisy, that is, there is variation in
processing and splicing not subject to regulation or conservation between species
(Melamud and Moult,  2009; Pickrell et al., 2010). Such aberrant transcripts should be
eliminated before they are translated to defective proteins, which is wasteful energy
use by the cell and may even produce harmful truncated proteins lacking critical
domains. While nonsense-mediated decay (NMD) targets frameshift transcripts during
the pioneer round of translation (see section 1.6.6), RNA quality control targeting
aberrant mRNAs begins already in the nucleus. The main mechanisms for quality
control are nuclear decay and/or retention at the transcription site (Schmid and Jensen,
2010). Both the export and decay machineries are linked physically to processing and
are recruited to the elongating polymerase, ready to monitor the processing as it
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occurs on the chromatin (Andrulis et  al., 2002; Kim et  al., 2004; Moore et  al., 2006;
Hessle et al., 2009). Inhibition of splicing by mutated splicing factors or mutation of
splicing reporters causes accumulation of the pre-mRNAs if decay is also inhibited
(Bousquet-Antonelli et al.,  2000).  Capping  and  polyadenylation  reactions  are  also
monitored, and failure to perform these processing steps leads to retention and/or
degradation (Hilleren et  al., 2001; Jimeno-González et al.,  2010).  The  decay  can
proceed  both  from  5ʹ to  3ʹ or  3ʹ to  5ʹ direction,  and  the  exoribonuclease  (exoRNase)
activities of both Xrn2/Rat1p and the RNA exosome complex are involved in nuclear
quality control (Bousquet-Antonelli et al., 2000; de Almeida et al., 2010; Davidson et al.,
2012).
1.6.2 Exosome
The exosome is a multiprotein complex with ribonuclease activities and consists of a
core of nine subunits, which are present in both in the nucleus and cytoplasm of
eukaryotic cells. The structure is highly conserved from archaea to metazoans, and is
also very similar to the eubacterial polynucleotide phosphorylase (PNPase) complex
(Schilders et al., 2006). The core subunits of the eukaryotic exosome have lost their
catalytic activity and the ribonuclease activity is instead provided by the associated
active subunits Rrp6 (also known as PM/SCL-100 in mammalian system) or Rrp44 (DIS3;
Liu et al., 2006; Dziembowski et al., 2007). In humans, two additional homologs of DIS3
have been discovered, called DIS3L1 and DIS3L2, both of which localize to the
cytoplasm but show differential association with the exosome core, as DIS3L1
associates with it while DIS3L2 does not (Staals et al., 2010; Tomecki et al., 2010; Astuti
et al., 2012; Malecki et al., 2013). RRP6 and DIS3L1 exoRNases degrade RNA only in the
3ʹ to 5ʹ direction, whereas DIS3 has both 3ʹ to 5ʹ exonucleolytic and endonucleolytic
activities (Lebreton et al., 2008).
The nine subunits of the core exosome form a barrel-like structure containing six
RNase PH-like proteins in a ring (Rrp41, Rrp45, Rrp46, Rrp43, Mtr3 and Rrp42) and
three  S1/KH  proteins  as  a  cap  on  one  side  of  the  ring  (Csl4,  Rrp4  and  Rrp40).
Rrp44/DIS3 is located on the opposite side of the ring from the S1/KH proteins. The
RNA takes a path through the barrel from the S1/KH side, through the barrel and into
the exonucleolytic active site of Rrp44/DIS3 (Makino et al., 2013). The exosome is able
to process structured RNAs because they are unwound during entry to the exosome
channel (Bonneau et al., 2009).
1.6.3 Exosome targets
The exosome targets a multitude of RNA species in the cell. It is involved in the
maturation of rRNA (ribosomal RNA), snRNAs and snoRNAs, degradation of RNAs that
are generated by pervasive transcription such as PROMPTs (promoter upstream
transcripts), CUTs (cryptic unstable transcripts), SUTs (stable uncharacterized
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transcripts) and XUTs (Xrn1-dependent unstable transcripts), different types of mRNA
decay such as nonsense-mediated, nonstop and no-go decay as well as AU-rich
element (ARE-) mediated decay (reviewed by Chlebowski et al., 2013). The exosome is
also  involved  in  a  checkpoint  of  nascent  pre-mRNAs,  as  pre-mRNAs that  fail  to  gain  a
poly-A tail are retained at the transcription site in an exosome-dependent manner and
are further degraded by the exosome at the same location (Bousquet-Antonelli et al.,
2000; Hilleren et  al., 2001). Recent transcriptome-wide work has indicated that the
exosome targets more than half of the yeast intron-containing genes (Gudipati et al.,
2012).  Similarly,  crosslinking  and  cDNA  sequencing  (CRAC)  experiments  in  yeast
revealed that DIS3 binds to intron-containing pre-mRNAs (Schneider et al., 2012).
It is difficult to conceive how an enzyme complex is able to target such variety of
substrates, yet do so in a controlled manner. One solution to this problem is that the
inactive core restricts the ribonuclease activities; another is that there are several
cofactor complexes that help in selecting targets. Of these, the Trf4/5p-Air1/2p-Mtr4p
polyadenylation (TRAMP) complex is an important auxiliary complex located in the
nucleolus and facilitates exosome activity by the helicase activity of Mtr4p and by the
addition of unstructured oligo-A stretches to RNA 3ʹ ends (Jia et al., 2011). In humans,
MTR4 also associates to the nuclear exosome-targeting (NEXT) complex (Lubas et  al.,
2011). MPP6 and C1D are additional factors that associate with the human and yeast
exosomes  and  are  required  for  exosome  targeting  to  rRNA  (Schilders et al., 2005;
Schilders et al., 2007).
1.6.4 Other nuclear degradation pathways
In addition to the 3ʹ to 5ʹ decay pathway, RNAs can be degraded in the 5ʹ to 3ʹ direction.
In the nucleus, this activity is provided by the XRN2 exonuclease (in yeast Rat1p). This
activity requires a free 5ʹend. Because the 5ʹ ends of the nascent pre-mRNA transcripts
are capped with an m7G cap as soon as they emerge from the RNA polymerase and are
bound by the cap-binding complex (CBC), they are protected from XRN2 degradation.
XRN2 can target pre-mRNAs if the cap is removed by decapping enzymes such as DCP2.
This can take place in the nucleus during pausing of Pol II -mediated transcription
(Brannan et  al., 2012). This leads to premature termination by the so-called torpedo
model, where the pre-mRNA is degraded in the 5ʹ to 3ʹ direction until the exoRNase
reaches the polymerase, and, together with other protein factors, causes the
polymerase to detach from the template (Luo et  al., 2006; Brannan et  al., 2012).
Decapping is also subject to quality control as defectively capped pre-mRNAs
accumulate in decapping deletion mutant yeast strains (Jiao et al., 2010). In mammals,
it is unclear whether XRN2 participates in quality control of capping. However, XRN2
has been shown to play a role in transcription regulation (Brannan et al., 2012; Eberle
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and Visa, 2014), and to monitor and degrade aberrantly spliced transcripts (Davidson
et al., 2012).
1.6.5 Kinetic proofreading hypothesis
As it has been difficult to pinpoint the mechanisms that would directly target aberrant
or unstable transcripts to the exosome, an alternative hypothesis on the selection of
exosome targets has been proposed (Burgess and Guthrie, 1993; Doma and Parker,
2007). According to the kinetic proofreading hypothesis, the fate of a transcript is
determined by competition between the rate of processing reactions and the rate of
decay reaction. Therefore, any transcripts showing delayed processing are more likely
to be degraded, and vice versa, in order to escape the kinetic surveillance, the rate of
the normal processing reaction should be optimal. In the case of pre-mRNA processing,
aberrant transcripts are retained in the nucleus, and correspondingly, splicing
enhances nuclear export (Legrain and Rosbash, 1989; Custódio et al., 1999; Zhou et al.,
2000; Audibert et al., 2002; Cheng et al.,  2006).  A  clear  advantage  from  such  a
targeting mechanism is that many kinds of defects can be recognized in this manner,
and no specific features of the transcript need to be recognized. This seems to be
applicable to the diverse nature of exosome targets.
1.6.6 Nonsense mediated decay
Cytoplasmic quality control represents a second checkpoint for monitoring the
accuracy of processed mRNAs. The NMD pathway targets transcripts that contain
premature termination codons (PTCs; Leeds et al., 1991; Lykke-Andersen et al., 2000).
In most cases it relies on the deposition of exon junction complexes during the process
of splicing (Zhang et al., 1998; Ishigaki et  al.,  2001).  An  EJC  marks  the  spot  on  mRNA
where an intron has been excised from. After export from the nucleus, mRNAs
associate with ribosomes in a primary round of translation. This process clears EJCs
from the mRNA, up to the point when the ribosome reaches a stop codon. At a normal
termination codon, release factors eRF1 and eRF3 together with poly-A binding protein
PABP (PABPC1 in mammals) stimulate efficient translation termination. If more EJCs
remain on the mRNA, that is, downstream of the stop codon, the release factors
interact with EJC proteins Upf2 and Upf3b to recruit Upf1, which is thought to trigger
degradation (Kashima et al., 2006). The distance between PTC and a downstream,
triggering EJC must be more than ~50 nt due to the size of the translation termination
complex and EJC. Termination at a PTC has also been found to be inefficient due to lack
of interaction with the poly-A tail and may in such case be independent of an EJC
(Amrani et al., 2004; Bühler et al., 2006; Ivanov et al., 2008). Instead, the activation is
determined by the length of the 3ʹUTR and the escape of transcripts with short 3ʹUTR
from NMD requires the binding of poly-A binding protein PABPC1 (Eberle et al., 2008;
Singh et al., 2008).
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1.6.7 Regulation via NMD
Besides targeting transcripts that contain premature termination codons due to
splicing  errors,  NMD  is  also  activated  in  a  regulated  manner  to  control  the  level  of
mRNAs. In this instance it often occurs in conjunction with alternative splicing (AS) and
is known by the acronym AS-NMD. Initial computational estimates suggested that for
genes with EST evidence for alternative splicing, as many as 35% could be potential
NMD targets (Lewis et  al.,  2003).  Examination  of  the  conservation  of  PTC+  isoforms
between mouse and human confirmed the importance of some AS-NMD events but
placed the estimate of frequency slightly lower, at 21% (Baek and Green, 2005). Large-
scale experimental evidence from yeast and mammalian cells suggests that 3-10% of
transcripts are targeted by NMD (He et al., 2003; Mendell et al., 2004).
Alternative splicing coupled to NMD appears to be especially common in the regulation
of splicing factor expression. This phenomenon was discovered in the SR splicing factor
family, which contain ultraconserved regulatory elements that lead to expression of
alternative splice forms, targeted by NMD (Lareau et al., 2007). Similar autoregulation
depending on AS-NMD has been described for PTB and other genes (Wollerton et al.,
2004; Ni et  al., 2007). Overexpression of the protein in question then leads to
increased inclusion of the PTC-containing exon, degradation by NMD, and a reduction
of splicing factor expression in order to restore homeostasis (Saltzman et al., 2008).
An snRNP can also participate in a negative feedback loop. Work by Rösel-Hillgärtner et
al. (2013) has shown that the U1 snRNP regulates its own proteins by binding to cryptic
5ʹ splice sites in an alternative cassette exon and enhancing the recognition of an
upstream 3ʹ splice site. Three cryptic sites in the U1-70K gene exert an additive effect
on the inclusion of an NMD-sensitive cassette exon, and the binding is influenced by
the levels of U1C and U1-70K proteins. As a result, the splicing choice regulates U1-70K
protein levels in a U1C-dependent manner.
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2 AIMS OF THE STUDY
This project began with the identification of a conserved sequence element in the
genes SNRNP48 and RNPC3, encoding two proteins of the minor spliceosome, U11-48K
and U11/U12-65K, respectively. The aims were to characterize the alternative splicing
regulated by this element, its activation in cells and the consequences for transcript
stability and localization. As the sequence element contained two matches to the U12-
type 5ʹ splice site consensus sequence, we hypothesized that there exists an
autoregulatory loop controlling the homeostasis of the U11/U12 di-snRNP.
Following this, the aim was to further characterize the distance requirements between
the two 5ʹss-like motifs and the splice sites they control. Since the alternative splice
site activation requires exon definition interactions to form between U12- and U2-type
spliceosomes, I investigated the communication between the spliceosomes and
specifically, the role of the U11-35K protein in it.
A long-standing question in the minor spliceosome field has been to pinpoint a role for
the maintenance of a parallel spliceosome in the genomes of many organisms,
especially  since  it  has  been lost  in  certain  lineages.  The  final  aim of  this  study  was  to
test the possibility that rate-limiting splicing by the minor spliceosome plays a role in
the nuclear processing of U12-intron containing transcripts on a transcriptome-wide
scale. This was done by studying the exosome-mediated degradation of pre-mRNAs.
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3 MATERIALS AND METHODS
Methods used in this study are listed in Table 2. For a detailed description of methods,
see the original publications.
Table 2. Methods used in this study.
Method Publication
Bioinformatic analysis III
Cell fractionation I, III
Cell lines and culture I, II, III
Immunofluorescence II
Immunoprecipitation I, II
In vitro splicing assays and spliceosome
assembly
I
In vivo splicing reporter assays I, II
Luciferase expression assays I
Northern blotting I, III
Protein overexpression in mammalian cells I, II, III
Quantitative RT-PCR I, III
RNA sequencing III
RNA-RNA crosslinking I
RNAi knockdown I, III
RT-PCR I, II, III
Sequencing library construction III
Site-directed mutagenesis II, III
Streptavidin pulldown assays I
Transfection I, II, III
Western blotting I, II, III
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4 RESULTS AND DISCUSSION
4.1 THE LEVELS OF U11/U12 DI-SNRNP ARE REGULATED THROUGH A
CONSERVED FEEDBACK MECHANISM (I, II)
4.1.1 Genes encoding U11-48K and U11/U12-65K contain highly conserved
sequence elements (I, II)
The recognition of U12-type introns relies on the cooperative binding of U11/U12 di-
snRNP  on  the  5ʹ splice site and branch point sequences (Frilander and Steitz, 1999).
Sequence-specific binding is achieved by both RNA-RNA base-pairing and protein-RNA
interactions, with U11-48K playing an important role in the 5ʹss recogniƟon (Turunen
et al., 2008; Tidow et al., 2009). In the course of our study into the 48K gene, SNRNP48,
we discovered a duplication of the U12-type 5ʹss sequence within its fourth intron. EST
evidence suggested that neither site functions as a splice donor.
Remarkably, the region containing the 5ʹss duplicaƟon within the 48K intron  4  was
conserved in evolutionarily very distant organisms. A closer inspection revealed that
the duplicated 5ʹss moƟf was present in the same intronic location of the 48K gene in
mammals, fishes and many insect species (see Figure 1A in I). In mammals the high
level of conservation is not limited to the duplicated 5ʹss moƟf, but also includes a
~110  bp  region  upstream  of  this  motif.  This  region  is  nearly  100%  conserved  and
contains a novel 8 nt exon, designated as exon 4i, which is surrounded by near-
consensus PPT, 3ʹss, and 5ʹss elements located ca. 50 bp upstream of the duplicated
5ʹss motif (I, Figure 1A). Outside the mammalian lineage the level of conservation
decreases, particularly in the region between exon 4i and the duplicated 5ʹss moƟf.
Between human and fishes the conservation is limited to the splice signals, the 4i exon,
and the duplicated 5ʹss motif, while between humans and insect species only the PPT,
3ʹss and duplicated 5ʹss motif are recognizable. Together, the sequence conservation
suggests that in addition to the duplicated 5ʹss motif, the upstream splice sites
constitute the main functional entities of this conserved intronic element. Surprisingly,
the duplicated 5ʹss motif  together  with  an  upstream  3ʹss was also detected in plant
48K genes, but in the 3ʹUTR  instead  of  an  intronic  locaƟon (Figure  1C  in  I).  The
presence  of  this  motif  in  the  same  gene  from  humans  to  plants  suggests  a  critical
cellular or organismal function.
Importantly, EST data provided evidence for two alternatively spliced mRNA isoforms
containing  exon  4i.  Both  show  an  activation  of  an  alternative  3ʹss upstream of the
duplicated U12-type 5ʹss-like motif and inclusion of exon 4i sequences, either alone or
together with intronic sequences downstream of exon 4i (see Figure 5). EST data was
confirmed by RT-PCR detection of both exon 4i-containing isoforms from endogenous
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genes and reporter constructs (Figure 4A in I; Turunen et al., 2013b). Similarly, plant
isoforms were identified by RT-PCR from A. thaliana and Populus trichocarpa (Figure S1
in I).
Figure 5. 48K and 65K splice isoforms. Black boxes represent coding exons, black lines represent
introns, and grey boxes represent untranslated regions.
Both 4i-containing isoforms are predicted to elicit NMD as they lead to appearance of
premature stop codons in the mRNA. Exon 4i inclusion leads to a frameshift in the
coding  sequence  and  the  appearance  of  a  PTC  close  by  downstream  in  exon  5.  With
the other isoform, which contains exon 4i and downstream intronic sequences, the
intron retention similarly leads to the insertion of a downstream PTC. These
observations led to a working model in which the 5ʹss-like motifs could function in
feedback regulation in a manner similar to AS-NMD described for SR proteins (Lareau
et al., 2007; Ni et al., 2007). In this hypothetical scenario, the binding of U11 snRNP or
U11/U12 di-snRNP would  lead  to  activation  of  an  upstream 3ʹss,  PTC  inclusion  and a
decrease in 48K mRNA levels via NMD. Given the central role of the 48K protein in 5ʹss
recognition, this would establish a negative feedback loop to regulate the 48K protein
levels and cellular homeostasis of U12-type intron recognition. The putative splicing
regulatory element containing the two U12-type 5ʹss-like motifs was named USSE, for
U11 snRNP-binding splicing enhancer.
Bioinformatic searches for USSE-like elements elsewhere in the genome resulted in
only one other hit that was evolutionarily highly conserved, namely RNPC3. This gene
codes for the 65K protein, which, similarly as the U11-48K protein, is a component of
the U11/U12 di-snRNP. Also in this case the USSE element is embedded within a highly
conserved region, located in the 3ʹUTR, thus resembling the plant 48K USSE (Figure 1B
in  I;  see  also  above).  It  is  also  associated  with  an  upstream  PPT  and  3ʹss, along with
isoforms displaying alternative splicing in the 3ʹUTR as detected by RT-PCR analysis
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(Figure  4B  in  I).  The 65K USSE element is conserved within vertebrates but was not
detected in other species.
In addition to sequence conservation, the distance between upstream 3ʹss and USSE,
and also the distance between the two 5ʹss-like elements within the USSE sequence,
both show a striking evolutionarily conservation (Figure 1 in II). In terrestrial
vertebrates (Tetrapoda), an overwhelming majority displayed exactly 63 nt distance
between 48K USSE and the upstream 3ʹss,  with  only  a  few  species  that  had  a  1-2  nt
variation in either direction. In the same group of species, 65K 3ʹss - USSE distance was
exactly 44 nt with only 1 nt variation. In fishes, the 3ʹss-USSE distance was slightly more
variable; nevertheless, fish 48K 3ʹss - USSE distances clustered closer to other
vertebrates’ 48K 3ʹss -  USSE  distance  and fish 65K 3ʹss - USSE with other vertebrates
65K 3ʹss - USSE distance. Insect 48K 3ʹss -USSE distance showed the largest variation,
with a range between 14 and 72 nt with little obvious clustering. In plants, the 3ʹss -
USSE distance is clustered between 34 and 41 nt and thus was similar to that in 65K
gene. This may reflect the fact that in both cases the USSE is located within the 3ʹUTR.
However, unlike in the mammalian 65K, there is more variation in element spacing in
plants, for example, a few plant species show very long 3ʹss - USSE distances (up to 121
nt).
Similar conservation was also observed with the length distribution of the spacer
separating the two 5ʹss-like elements within the USSE (Figure 1B in II). With tetrapod
species 48K USSE  seems  to  favor  a  9  nt  spacer  length  with  only  a  few  exceptions.
Interestingly, 65K USSE in the same phylogenetic group typically has a 6 nt spacer,
again with very little variation. Plant USSE spacers are most often 3 nt in length with
only a few exceptions. Fish and insect spacer lengths are more variable and do not
seem to correlate with location of the USSE (48K vs. 65K).
Together, the phylogenetic data suggests that the upstream 3ʹss (including PPT) and
the USSE sequence itself are the central elements needed for alternative splicing
regulation. In addition to sequence conservation, both the distance between the 3ʹss
and USSE and the length of the spacer between the 5ʹss-like motifs are maintained
within strict limits. The strong evolutionarily conservation detected in the phylogenetic
analysis suggests that these parameters are important at cellular or organismal level
and subject to purifying selection. It also suggests that deviations from these
parameters would have downstream consequences at the level of U12-type intron
recognition or splicing.
4.1.2 Both USSE motifs bind U11/U12 di-snRNP (I, II)
To confirm the proposed model of the feedback regulation above, the binding of the
U11/U12 di-snRNP to the USSE was investigated initially using in vitro splicing
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conditions. In vitro transcribed RNA substrates containing 48K USSE sequences were
incubated in HeLa nuclear extracts and the resulting complexes were resolved on
nondenaturing gels (Figure 2 in I). Two complexes migrating similar to a spliceosomal A
complex were observed with wt RNA, and were lost with an RNA substrate that
contained the A+3G mutations that inhibit binding of the 48K protein to the canonical
U12-type 5ʹss (Figure 2B in I; Turunen et al., 2008). The binding properties of the USSE
element were studied further with pulldown of biotinylated RNA substrate with either
48K or 65K USSE element, followed by the identification of copurifying small  RNAs on
northern blots (Figures 2D-F in I). In these experiments it was observed that both U11
and U12 snRNAs associate with USSE sequences, and the association is dependent on
the functionality of the 5ʹss-like motifs. Mutations that disrupt the binding of either
48K  (A+3G  as  above)  or  U11  snRNA  (CC+5/6GG)  lead  to  reduction  of  U11  and  U12
snRNA  association.  To  achieve  a  complete  loss  of  U11/U12  binding,  both  5ʹss-like
motifs need to be mutated.
The above results were confirmed by psoralen crosslinking (Figure 3 in I). Both U11 and
U1 snRNAs, but not U12, formed crosslinks with 48K substrate. U11-specific crosslinks
were dependent on the functional U12-type 5ʹss sequence suggesƟng that U11 snRNA
base-pairs with the USSE sequence, while the lack of crosslinks to U12 snRNA suggests
it does not form base-pairing interactions with the substrate but is associated to USSE
in the pulldown experiments (Figures 2D-F in I) due to the recruitment of the entire di-
snRNP. In contrast, U1 associates with the U2-type 5ʹss that is present in the
crosslinking substrates (Figure 3B in I). The indispensable role of U11 snRNA on USSE
recognition was unequivocally shown with a rescue experiment in which USSE
mutations that prevent base pairing between U11 snRNA can be rescued by
coexpression of a U11 snRNA containing compensatory mutations in vivo (Figure 4F in
I).
One of the key questions was the function of the 5ʹss duplicaƟon within the USSE
element:  are  two  U11  (or  U11/U12)  snRNPs  binding  to  the  two  5ʹss sequences, or is
the function of the duplication to increase the probability that a single U11 snRNP
binds? In this respect the in vitro experiments provide ambiguous results: with the pull-
down experiment (Figure 1 in I), mutations to either 5ʹss element decrease the amount
of U11 snRNA in the pellet roughly by 50 %, which suggest either that two U11 snRNPs
are binding simultaneously, or that high-affinity binding of a single U11 requires a
duplicated site. In contrast, in crosslinking experiments (Figure 3 in I) mutations of
individual 5ʹss elements did not aﬀect the crosslinking eﬃciency of the other site. This
suggests that a single 5ʹss site is suﬃcient for U11 binding.
In contrast, both the in vivo and phylogenetic data suggest that both U11 binding sites
are needed for the activation of the upstream 3ʹss. If either one is targeted by
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mutations that prevent the binding of U11-48K protein (A+3G) or U11 snRNA
(CC+5/6GG or CT+6/7AG) the result is a complete loss of alternative splicing with either
48K or 65K reporter construct (Figures 4A,B,F in I). Strong evidence supporting the
binding of two U11 snRNPs to a single USSE sequence comes from the rescue
experiment mentioned above (Figure 4F in I). This experiment showed that two
different U11 snRNAs (wt and one containing compensatory mutations) are needed for
the 3ʹss acƟvaƟon when one of the 5ʹss moƟfs has been mutated to prevent the
binding of wt U11 snRNA. The ultimate support to this model comes from experiments
aiming to identify the minimal 5ʹss -5ʹss spacer length within the USSE element able to
support the activation of the upstream 3ʹss splice site (Figure 1D in II). There, reduction
of the spacer length below 3 nt resulted in a strong inhibition of activation of upstream
3ʹss. Given that  even  with  0  nt  spacers  both  5ʹss  moƟfs  are  expected  to  be  fully
functional for binding of a single U11 snRNP, the interpretation of these results is that
5ʹss elements that are too close lead to a steric clash of the two U11/U12 di-snRNP
particles, reducing or disabling the activity of the USSE.
Interestingly, lengthening the 65K spacer beyond the wild type 6 nt resulted in only
slight reductions in splicing efficiency up to 30 nt (longest spacer tested; igure 1E in II).
A  9-nt  spacer,  which  is  the  length  of  the  majority  of  vertebrate 48K USSE spacers,
supported normal levels of the long isoform. This result supports the above notion that
both 5ʹss sequences within the USSE element are occupied by a  U11 snRNP,  but  also
indicate that there is a stabilizing interaction between the complexes assembled on the
individual 5ʹss sequences. In contrast to the situaƟon where spacer shortening can lead
to a steric clash, the minimal effect of long spacers can be explained by flexibility of the
single-stranded RNA spacer, which allows the spacer to loop out to support
interactions between distantly spaced U11 snRNPs.
Together, both the in vitro and in vivo data indicate that USSE elements are recognized
by U11 snRNP or U11/U12 di-snRNP. U12 snRNP most likely does not have any direct
role in the USSE recognition, but rather is a passive component participating through
binding to U11 snRNP. In vivo evidence provides a strong support that both 5ʹss
elements are recognized simultaneously. It is possible that the two U11 or U11/U12
snRNPs bound to USSE are stabilizing each other’s binding through currently
undiscovered interactions. The role of such interactions would be to stabilize U11:5ʹss
recognition in the absence of U12:BPS interaction that normally occurs during the
splicing of U12-type introns (Frilander and Steitz, 1999).
4.1.3 Feedback mechanism relies on alternative splicing and exon
definition interactions (I, II)
To confirm the biochemical evidence on USSE-dependent activation of the upstream
3ʹss we carried out in vivo investigations targeting both endogenous 48K and 65K genes
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and also used splicing reporters containing the USSE elements. The 48K USSE reporter
contained a previously described SmE minigene reporter (Pessa et  al., 2006), with an
insertion of the 48K 4i exon and surrounding sequences. Transfected to HEK293 cells,
the wild-type reporter mRNA is processed to yield two isoforms, the majority of which
excluded exon 4i and a minority with exon 4i inclusion (Figure 4A in I). Mutation of 48K
(A+3G mutation) or U11 binding sites (CC+5/6GG) abolished 4i exon inclusion. Similar
responses were observed for a reporter containing a firefly luciferase gene in
association with the 65K 3ʹUTR (Figure  4B  in  I).  This  reporter  produced a  short  3ʹUTR
when no USSE activation takes place and a long 3ʹUTR when USSE is activated, as
supported by mutation and oligo blocking experiments. Analogously to the 48K USSE
reporter, mutations of 48K (A+3G as above) or U11 (CC+5/6GG as above or CT+6/7AG)
binding sites abolished the long isoform.
Next, the endogenous alternative splicing pathway was investigated using
overexpression of 48K cDNA from plasmid (“r48K”) and antisense oligonucleotides
binding to USSE to block U11 snRNA base-pairing (“block” oligo). A mock oligo binding
to a nonconserved downstream site was used as a control. We found that the
overexpression of 48K dramatically increases the inclusion of exon 4i, and this splicing
activation was attenuated with the blocking oligo (Figure 4C in I). The endogenous 65K
alternative splicing also responded to the oligo block (Figure 4D in I). These results
support the previous result showing that the USSE sequence is necessary for the
activation of the upstream 3ʹss.
We then tested whether reduction of minor spliceosome protein levels would affect
the feedback loop. We inactivated 48K, 35K, or 20K using RNAi, and found that the
knockdown of 35K produced a 3-4 fold upregulation of both 48K and 65K mRNAs
(Figure  5C  in  I).  This  knockdown  also  caused  a  shift  in  the 65K 3ʹUTR isoform raƟo,
leading to a marked increase in the short isoform levels and an almost complete loss of
the long isoform (Figure 5E in I). Knockdown of 48K produced a similar upregulation
and isoform switch in 65K mRNA, whereas knockdown of 20K, another protein of the
di-snRNP but with no known function in 5ʹss recognition, had very little effect (Figure
5D,E  in  I).  The  strong  effect  of  35K  knockdown  suggests  that  35K  is  involved  in
interactions that enhance recognition of the upstream U2-type splice sites. This is
supported by the observation that the 35K protein structure is similar to that of U1-
70K, which in the major spliceosome is involved in exon definition interactions (Will et
al., 2004).
Since 35K knockdown had such a dramatic effect on the 48K and 65K mRNA levels, we
investigated the USSE-mediated activation of alternative splicing using reporters that
replace USSE with four λN hairpin loops (Gehring et al., 2008) within the context of the
65K 3ʹUTR (Figure 2A in II). 35K was tagged with the λN peptide that binds to the
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hairpin, and with a V5 peptide for immunodetection. The hairpin reporter on its own
was inactive with regard to splicing to the long isoform 3ʹss, but tethering 35K to the
reporter restored alternative splicing, albeit with lower efficiency than seen with the
wt USSE (Figure 3C in II). Mutating the 35K RRM to prevent association with the U11
snRNA  did  not  eliminate  reporter  splicing;  in  fact,  there  was  a  slight  increase  in  long
isoform levels. This suggests that the RS domain of 35K is the most likely candidate for
interacting with upstream factors involved in 3ʹss recogniƟon. To conﬁrm this
interpretation we inactivated the RS domain by changing all its arginine residues to
alanines. This led to a loss of 3ʹss acƟvity and is consistent with the well-known role of
the RS domain in splicing activation and localization (Cazalla et al., 2002). Consistently,
the paralog of U11-35K in the major spliceosome, U1-70K, and its RS domain alone,
was  able  to  substitute  for  35K  in  3ʹss acƟvaƟon when tethered to reporter construct,
leading to 3ʹss acƟvaƟon at a level similar to the wt USSE. The most likely explanation
for strong activation with U1-70K constructs is that it contains two stretches of
DR/ER/SR dipeptide repeats, whereas 35K has only one stretch, which is equivalent in
length to one 70K RS repeat. Earlier studies with other splicing factors have shown that
that the number of SR dipeptides is proportional to the potency of activation (Philipps
et al., 2003).
Given the phylogenetic conservation of the 3ʹss - USSE distance (see 4.1.1) ,  we asked
whether there is a minimal distance in the human 65K USSE system needed to support
exon definition interactions between the USSE and the upstream 3ʹss.  We  found  a
progressive loss of 3ʹss acƟvaƟon upon shortening of the 3ʹss -  USSE  distance,  with
virtually no 3ʹss activity when the distance was 0 nt (Figure 1D in II). This observation is
consistent with the hypothesis that the 3ʹss - USSE distance has been selected to
accommodate the binding and interaction of U11 snRNP and the 3ʹss-binding factors.
In exon definition of constitutively spliced exons, it has been observed that shortening
of an exon from 50 to 33 nt causes it to be skipped (Dominski and Kole, 1991), and
similar results have been obtained with alternative splice sites regulated by U1 snRNP
(Hwang and Cohen, 1997). This distance may represent an approximate lower limit
that accommodates 3ʹss -  5ʹss bridging interacƟons; however, very short exons are
sometimes efficiently spliced (Berget, 1995).
4.1.4 USSE activation regulates stability and localization of 48K and 65K
mRNAs (I)
Activation of the upstream 3ʹss by the USSE in 48K mRNA is predicted to lead to decay
by the NMD pathway, as the inclusion of the 8-nt exon leads to a frameshift and
eventual inclusion of a PTC with both USSE-induced mRNA isoforms. In the case of the
exon 4i-containing transcript this was experimentally verified using the translation
inhibitor  cycloheximide  (CHX;  see  Figure  5A  in  I).  As  NMD  is  activated  during  the
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pioneer round of translation (reviewed by Maquat et al., 2010), inhibition of protein
synthesis is expected to stabilize any NMD target. Consistently, both CHX treatment
and expression of a dominant negative form of Upf1 (Figure 5B in I; Lykke-Andersen et
al., 2000), an essential NMD factor, led to a substantial stabilization of exon 4i
containing mRNAs, indicating that the 48K mRNA  is  indeed  targeted  by  the  NMD
pathway.
In contrast, with the 65K mRNA, CHX treatment did not lead to stabilization of the long
isoform (Figure 5F in I), consistent with the location of the alternatively spliced 3ʹss
within ca. 50 nt of the actual translation termination codon. Instead, the 65K short
3ʹUTR,  when  cloned  to  a  luciferase  reporter  and  assayed  for  luciferase  acƟvity,
produced 2-3 fold higher luciferase signals than the long 3ʹUTR (Figure  5G  in  I).
Furthermore, an equimolar cotransfection of the long and short 3ʹUTR reporters led to
the expression of the short isoform in both nucleus and cytoplasm, as assayed by
fractionation (Figure 5G in I),  whereas the long 3ʹUTR reporter was retained mainly in
the nuclear fraction. The endogenous 65K mRNAs localized in the same way (Figure 5H
in I). Overall, the luciferase activity and both the reporter and endogenous mRNA
localization support two nonconflicting models, whereby the 65K long  3ʹUTR mRNA
would either be retained in the nucleus, and/or the cytoplasmic long isoform would be
destabilized. Interestingly, in a related study, it was found that the longer 4i-containing
48K transcript was not stabilized with CHX treatment (Turunen et al., 2013b). Rather, it
was speculated that the presence of the USSE element in the mRNA (as opposed to
removal of the USSE sequence via splicing, as in the exon 4i-only isoform) may have led
to nuclear retention of this transcript.
What are the implications and the extent of the USSE-mediated regulation of the 48K
and 65K mRNAs? Remarkably, the qPCR quantification above indicated (4.1.3) that up
to 75% of the transcripts were directed to the decay pathway. This suggests that the
level of both the transcripts and also their protein products are actively downregulated,
at least in the cell lines used in this study. It is not known whether this autoregulatory
feedback loop can be regulated differentially in other conditions or cell types. The
hnRNP H/F proteins identified as critical negative factors regulating the activation
signals by the USSE element may represent an example of an additional regulatory
layer (Honoré et al., 2004; Turunen et al., 2013b).
4.1.5 The function of the USSE and evolutionary implications
Splice site sequences, including U12-type splice site-like motifs, have previously been
observed by others to function as splicing regulatory elements (see section 1.4.6;
Hwang and Cohen, 1997; McNally and McNally, 1999; Lewandowska et al., 2004; Wang
et al., 2004; Yeo et al., 2007; Dhir et  al., 2010). In contrast to the present work they
have been mostly shown to act as negative regulators, typically suppressing the
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recognition of pseudo splice sites in in vitro splicing reactions, or they have been
identified in SRE screens as inhibitory elements. The mode of action in such cases has
been proposed to be a direct blocking of productive interactions by steric hindrance, or
by destabilization of the binding of other splicing factors. Some of these cases differ
from the USSE system in having binding sites very close to the elements that are being
inhibited (Hwang and Cohen, 1997; Lewandowska et al., 2004; Dhir et al., 2010). In
contrast, with the USSE, it is likely that the distance between the element and the
target site can accommodate both USSE-binding di-snRNPs and proteins and snRNPs
recognizing the actual splice sites.
Given that a large group of spliceosomal proteins, and also proteins functioning more
generally in RNA processing, are regulated by a feedback mechanism (Saltzman et al.,
2008), it is likely that similar negative feedback loops involving spliceosomal complexes
will  be  identified.  Indeed,  a  very  recent  work  described  the  feedback  regulation  of  a
major spliceosome component (the U1-70K protein) that operates by very similar
principles as the USSE system (Rösel-Hillgärtner et al., 2013). In that case, activation of
an alternative 3ʹss within the U1-70K mRNA is regulated by U1 snRNP binding to
unproductive U2-type 5ʹ splice site sequences located downstream. High levels of
functional U1 snRNP lead to U1 binding to the unproductive 5ʹ splice sites and to the
activation of the upstream 3ʹss, presumably using exon deﬁniƟon interacƟons similar
to the USSE-mediated alternative splicing. Alternative 3ʹss acƟvaƟon introduces a PTC
in the U1-70K mRNA and leads to decay via NMD. The recognition of the unproductive
5ʹ splice sites is regulated through the cellular levels of U1-C protein (a functional
analog of the U11-48K protein). Thus, like the USSE, the system controls the cellular
U1-70K/U1-C homeostasis needed for correct U1 snRNP assembly. The identification of
analogous feedback systems in both splicesomes, that regulate the cellular
homeostatic of the central snRNP protein components, suggests that such stringent
control is necessary for the correct functioning of both spliceosomes.
With the U12-dependent spliceosome the need for correct 48K protein levels is
obvious, as it has been shown that a significant reduction in the cellular levels of 48K
leads not only to failure to splice U12-type introns and intron retention, but also to the
activation of nearby cryptic U2-type splice sites (Turunen et al., 2008). This can
severely compromise the expression of genes containing U12-type introns by
introducing insertions or deletions that can compromise the function of the proteins or
lead to NMD-mediated decay of the incorrectly spliced mRNAs. Similarly, mutations of
the human 65K that impair its normal function in bridging the U11 and U12 snRNPs to
form the U11/U12 intron recognition complex lead to a developmental disorder,
presumably as a consequence of activation of cryptic U2-type splice sites and other
missplicing events (Argente et  al.,  2014).  Therefore,  as  the  correct  level  of  these  two
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proteins is necessary for the recognition of U12-type introns, it is conceivable that the
levels of both proteins are being regulated through similar feedback systems.
One  way  to  explain  the  existence  of  the  intricate  feedback  regulation  of  U12-
dependent spliceosome components is the need to maintain the observed slow
processing of U12-type introns, which in turn provides the rate-limiting regulation for
the genes with U12-type introns (III; Patel et al., 2002; Patel and Steitz, 2003). However,
it is unclear whether intron recognition would be the appropriate step to regulate
splicing rate, because, as discussed above, failure to recognize a U12-type intron can
activate nearby cryptic U2-type splice sites. Therefore, if the slow splicing of U12-type
introns is under regulatory control, then it is conceivable that the rate-limiting
regulatory step should be after the intron recognition step (see 4.2.3). Interestingly, in
vitro splicing data indicate that while the intron recognition (A-complex assembly) is
relatively fast with the U12-type introns, the subsequent activation step seem to be
rate-liming (Frilander and Steitz, 1999). Consistently, recent work has suggested that
U6atac snRNA levels can be regulated via signaling pathways to influence the efficiency
of U12-type intron removal (Younis et al., 2013), suggesting that tri-snRNP levels
regulated through U6atac availability could provide the means to regulate the slow
splicing of U12-type introns. Furthermore, as the 65K protein has been shown to bind
not only the U12 snRNA (Benecke et al., 2005), but also U6atac snRNA (Benecke, 2004),
it is also possible that the feedback regulation of the 65K levels are linked to the
efficiency of tri-snRNP recruitment to the spliceosome, therefore providing the means
to regulate the speed of U12-type intron removal.
While the USSE sequence itself can be found from humans to plants, suggesting an
ancient evolutionary origin, its presence in variable locations (either intronic or 3ʹUTR)
suggests that it may have arisen on several occasions during eukaryotic evolution. 65K
USSE appears to be a more recent addition as it is present in all vertebrates but not in
any other species of the present study (Figure 7 in I). Since it brings also 65K under the
influence of the feedback loop, the function of USSE in the 65K may be to provide an
even more stringent level of regulation, suggesting that for vertebrates, the regulation
of minor spliceosome activity may be of crucial importance. This is also supported by
the strict conservation of the USSE distance parameters in vertebrates (II). On the
other hand, the absence of the USSE in either 48K or 65K in some lineages suggests
that it has been lost from either gene on several occasions, possibly concomitant with
the reduction in the number of U12 introns (e.g. in Diptera) or in combination with the
loss of rate-limiting regulatory function of U12-type introns.
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4.2 U12-DEPENDENT TRANSCRIPTS ARE SPLICED LESS EFFICIENTLY
AND TARGETED TO NUCLEAR DEGRADATION (III)
4.2.1 Exosome inactivation leads to stabilization of intron-retaining
transcripts
It has been long known that U12-type introns are spliced less efficiently than the major
type introns (Tarn and Steitz, 1996b; Frilander and Steitz, 1999; Patel et al., 2002).
However, it was not known whether the slow splicing of U12-type introns is a global
phenomenon. Similarly, the subsequent fate of the transcripts containing unspliced
U12-type introns has not been investigated. We hypothesized that U12-type intron
retention would lead to increased dwell times in the nucleus, which would expose the
unspliced transcripts to nuclear surveillance pathways that target nuclear RNAs based
on their processing efficiency (a process called kinetic proofreading; see section 1.6.5).
To test the potential interconnections between the minor spliceosome and nuclear
quality control pathways, we disabled various RNA degradation pathways by knocking
down different decay factors that are known to function in the nuclear quality control,
including RNA exosome components and the 5ʹ to 3ʹ decay factors. The expectation
was that relevant pathways would show a stabilization of unspliced U12-type introns
signals upon the knockdown. Initially, we assayed intron retention in three genes,
VPS16, MAPK12, and RCD8, which each contain either 1 or 2 U12-type introns (III,
Figure 1A). The U12-type introns in these genes are relatively short, which permits
simultaneous amplification of unspliced pre-mRNAs and spliced exon-exon junctions
using primers in the flanking exons. We found that knockdown of the exosome core
subunit RRP41 produced the most robust and reproducible stabilization of unspliced
U12-type transcripts, whereas the knockdown of exonuclease subunits DIS3 and RRP6
produced milder effects (Figures 1 and S1 in III). Other exosome subunits tested (data
not shown) or 5ʹ to 3ʹ decay factors XRN2 and DCP2 had no effect on transcript stability
(Figures 1 and S1 in III). The stabilization of U12-type introns caused by RRP41
knockdown was partially rescued by the overexpression of RRP41 with silent point
mutations in the siRNA target site (Figure 1D,E in III).
4.2.2 U12-type intron retention on global scale
Since the inefficient splicing of U12-type introns has previously been reported only in a
handful of genes, we decided to investigate this on a transcriptome-wide scale. Control
and knockdown cells were fractionated and the resulting RNA pools were sequenced.
First we compared the retention levels of U12-type introns to their neighboring U2-
type introns in the control knockdown, and found that they were on average two times
higher  (Figures  2C  and 3G in  III).  This  reproduces,  on  a  transcriptome-wide  scale,  the
previously reported small-scale findings of increased U12-type intron retention (Patel
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et al., 2002; Pessa et  al., 2006). After knockdown of exosome subunits, 119 introns
were differentially retained with statistical significance in either knockdown. 80% of
these were identified in the RRP41 knockdown, and a majority of these were stabilized,
as expected (Figure 3A,B in III).
The fold change values were larger in the RRP41 knockdown than for DIS3; in fact, the
fold change distribution of the whole set of U12-type intron-containing genes shifted
to stabilization in RRP41 knockdown (Figure 3E in III). DIS3 knockdown, in addition to
intron stabilization, showed considerably more intron destabilization than RRP41
knockdown (Figure 3C,F in III). Finally, the overlap between stabilized introns in the
two knockdowns was larger and statistically significant, whereas the overlap in
destabilized introns was smaller and only marginally significant (Figure 3C in III). The
reasons for the partial discrepancy between the DIS3 and RRP41 knockdowns are not
known, but it is possible that DIS3 may be compensated by other exoRNases that
associate with the exosome core, even to such an extent that the expression of
alternative exoRNases is stimulated (Tomecki et  al., 2010). This could lead to the
observed destabilization of the introns not shared with the knockdown of RRP41.
We hypothesized that if the inefficiency of splicing makes U12-type introns susceptible
to nuclear degradation, then the more slowly spliced the intron is, the more likely it is
degraded. Thus, we attempted to identify a signature of such inefficiently spliced
introns by analyzing intron characteristics such as splice site score, subtype (AT-AC vs.
GT-AG), but found no correlation between these characteristics. Also, we reasoned
that maybe larger introns and downstream introns are more likely to be retained and
therefore more likely to be targeted, but again there was no correlation. Neither could
we find enrichment or absence of sequence motifs that would suggest regulation by
splicing factors.
To control for any effects that the exosome knockdown might directly have on the
efficiency  of  U12-type  splicing,  we  performed  several  controls.  First,  we  probed  on
northern blots that the knockdowns did not affect the levels and sizes of minor
spliceosomal  snRNAs  (Figure  S2A in  III).  Second,  we confirmed from the  RNAseq data
that the expression of minor spliceosome-specific proteins is not changed in the
cytoplasmic fraction (III, Figure S2D). Third, we counted U12-type exon-exon junction
reads in the nuclear fraction, which represent the efficiency of splicing for nascent
RNAs (III, Figure S2B). In fact, we found that with both of the subunit knockdowns, the
number of junction reads increased. This is consistent with the kinetic proofreading
hypothesis, as the knockdown of exoRNase activity allows the splicing of more U12-
type intron-containing transcripts to reach completion. However, there were very few
genes containing U12-type introns whose cytoplasmic expression changed after the
exosome knockdown.
51 Results and discussion
Finally, we did not find evidence of cryptic splicing of U12-type introns after exosome
knockdown. It has been shown that when the U12-type recognition is impaired, nearby
cryptic U2-type splice sites are often activated (Turunen et al., 2008; Argente et al.,
2014). As we did not find any evidence of increased levels of cryptic splicing near U12-
type introns after the exosome knockdown, we conclude that U12-type introns have
been correctly recognized by the U11/U12 di-snRNP in the transcripts that are targeted
for decay by the nuclear surveillance pathways. Instead, a subsequent slow step in
spliceosome assembly or catalysis, as discussed earlier (section 4.1.5), leads to a slow
splicing and nuclear decay.
4.2.3 U12- and U2-type introns show differential decay rates
To confirm the slower splicing kinetics and the effect of the exosome knockdowns we
investigated  the  decay  rates  of  a  subset  of  pre-mRNAs  in  control  and  exosome
knockdown  cells.  The  cells  were  treated  with  DRB  (5,6-dichloro-1-β-D-
ribofuranosylbenzimidazole), an inhibitor of CDK7 phosphorylation and of Pol II
progression from initiation to elongation, and the decay of three U12-type introns was
followed  by  RT-qPCR  (III,  Figure  4C).  The  genes, STX10, MORC4, and CHD1L, were
chosen from the group of stabilized introns so that the total length of pre-mRNA would
not be very large (i.e. they would complete transcription within 15 min following the
introduction of DRB) and the locations of the U12-type introns would vary (i.e. located
at  the  5ʹ, middle and 3ʹ part of the transcript, respecƟvely). One U2-type intron from
each gene was analyzed as a control, and was chosen to match the length of the U12-
type intron as well as possible.
We found that the half-lives of the U2-type introns in the DRB experiment were
surprisingly long, 30-60 min, and showed little change upon exosome knockdown. In
contrast, the half-lives of U12-type introns, approximately 90-150 min in control cells,
were further increased by 1.5 to 2-fold upon exosome knockdown. Additionally, the
RT-qPCR data also showed the increased levels of transcripts containing U12-type
introns for each gene tested. The interpretation of these experiments is that while the
decay of U2-type pre-mRNA signal results predominantly from the cotranscriptional
splicing as the exosome knockdown did not have a strong effect on the decay rate, a
significant fraction of transcripts containing U12-type introns are targeted by the
nuclear exosome. Considering that U2-type introns are removed cotranscriptionally in
the 5ʹ to  3ʹ order they emerge from Pol II (Pandya-Jones and Black, 2009), our data
suggest that U12-type introns may deviate from this processing order and are removed
last.
Previous work on the kinetics of pre-mRNA splicing has shown that U12-type introns
can be spliced cotranscriptionally, as the initial RT-qPCR signals for successful splicing
of U12-type introns after the start of transcription appear before Pol II has finished
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transcription (Singh and Padgett, 2009). This is consistent with the detection of the
snRNA components of the minor spliceosome in the chromatin fraction in cell
fractionation experiments (Tilgner et  al., 2012). On the other hand, our kinetic data
suggest that at least with a subset of genes a significant fraction of the U12-type
splicing occurs post-transcriptionally. Interestingly, after exosome knockdown, the
U12-type intron decay kinetics show a relatively long lag period following the addition
of DRB, during which no decay takes place. This observation suggests that splicing does
not occur at these introns for a considerable time period after the splice sites emerge
from Pol II.
Taken together, the transcriptome-wide study confirms that the majority of U12-type
introns, over 70% (III, Figure 3G), are retained to a larger extent than their U2-type
neighbors. While the highly conserved regulatory loop may not explain the inefficiency
of U12-dependent splicing, pre-mRNAs with retained U12-type introns are stabilized
following exosome inactivation. The strong upregulation of the pre-mRNA signals
together with considerably delayed decay kinetics suggest that, under steady-state
conditions, U12-type splicing is indeed rate-limiting. The slow removal causes a
substantial fraction of the nascent U12-type intron containing pre-mRNAs to be
degraded before reaching cytoplasm, and therefore, is highly important for
maintaining the correct expression level of genes with U12-type introns.
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5 CONCLUDING REMARKS
Since the discovery of the U12-dependent spliceosome, the maintenance of two
parallel spliceosomes in many eukaryotic lineages has remained an enigma. The minor
spliceosome is clearly essential for the development of the organisms that retain it, yet
U12-type introns are easily lost via mutagenesis and conversion to U2-type introns,
and some lineages have lost the U12-dependent spliceosomal components altogether.
This work has shown that not only are the introns and spliceosomal components
conserved in plant and animal species, but also the regulatory elements that control
the abundance and activity of critical subunits show remarkably strict conservation.
The function of the USSE autoregulatory loop is to maintain the intron recognition
components of the minor splicing pathway at optimal levels. Deviation from this
homeostasis would lead to intron retention or activation of U2-type cryptic splice sites
in the vicinity of the unrecognized U12-type introns, and potentially harmful
missplicing events.
The hypothesis of rate-limiting U12-type introns in gene expression is well established,
but it has not been established whether all U12-type introns are inefficiently removed.
The transcriptome-wide results in this work show that the majority of U12-type introns
indeed are retained when compared to U2-type introns. The data presented here on
the kinetics of U12-type intron decay indicate that there is a considerable delay in the
processing of these introns. The lack of cryptic splice site usage in the RNAseq data
suggests, however, that the processing is stalled after splice site recognition. Therefore,
the rate-limiting step of U12-type splicing pathway may not be intron recognition but
instead further downstream. Indeed, multiple arguments point to the availability of
U6atac contributing to the rate limiting step of the pathway.
Finally, the rate-limiting hypothesis implies that regulating the activity of U12-
dependent spliceosome is important for maintaining correct removal rates, and it can
be further speculated that its activity may be different under some physiological
conditions. Until recently there has been no evidence on how the U12-dependent
spliceosome activity could be regulated. The current work on the feedback loop
regulation, together with other recent publications, has opened the field for the study
of minor spliceosome regulation.
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